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Many cancer patients can benefit from proton therapy, as the treatment modality have 
been shown to provide a more conformal irradiation of the target while sparing 
surrounding healthy tissue, compared to photon therapy. The concept of the relative 
biological effectiveness allows for appliance of the large amount of experience from 
photon therapy when considering irradiation with protons. In proton therapy treatment 
today, a constant proton RBE of 1.1 relative to high-energy photons is applied, 
assuming protons to be 10% more effective for the same physical dose. However, the 
proton RBE have been shown to vary with multiple physical and biological factors 
including the deposited physical dose, irradiated tissue and radiation quality of the 
beam. Precise modelling of the proton RBE have therefore become an important field 
of study.  
This work presents a comprehensive analysis of proton RBE dependencies, using a 
large up-to date database of in vitro data points from proton irradiation experiments. 
The analysis focus on the RBE dependence on the reference radiation fractionation 
sensitivity ((𝛼 𝛽⁄ )𝑥), and the radiation quality of the beam, quantified by the linear 
energy transfer (LET). Additionally, potential differences between RBE of 
monoenergetic and broad energy proton beams (for a given average LET value) was 
explored, and the effects of variations in the data selection procedure were investigated. 
The widely used assumption of an inverse proportionality of RBE with (𝛼 𝛽⁄ )𝑥 was 
investigated through linear fitting and the fits were compared with previous published 
models applying this assumption. The RBE-LET relationship was investigated by 
fitting of polynomials from 1st to 4th degree and polynomials of 1st and 2nd degree in 
combination with exponential functions. Additional fitting was performed on different 
restricted databases in terms of reduced range of included LET and (𝛼 𝛽⁄ )𝑥 values. 
Furthermore, the database was seen to be highly imbalanced, i.e. data points were not 
evenly distributed over the (𝛼 𝛽⁄ )𝑥 and LET range, and fitting was therefore also 
performed using an iterative sampling procedure to compensate for this. Selected 
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regression fits were implemented as RBE models and the RBE estimates from these, 
both as a function of LET, dose and (𝛼 𝛽⁄ )𝑥 and for a simulated spread out Bragg peak 
(SOBP) scenario were compared to the estimates of three published RBE models.  
Linear fitting on both the unrestricted and restricted databases showed a trend of a 
steeper increase in RBE with increasing LET when an SOBP beam is used, compared 
to applying a monoenergetic beam. Analysis of the (𝛼 𝛽⁄ )𝑥 dependency implied that 
appliance of the 1/(𝛼 𝛽⁄ )𝑥 assumption might lead to overestimated RBE at  (𝛼 𝛽⁄ )𝑥 
values below approximately 6 Gy, and underestimated RBE predictions for higher 
(𝛼 𝛽⁄ )𝑥. Therefore, a less strong dependency of (𝛼 𝛽⁄ )𝑥 for the proton RBE should be 
considered further. Fitting on restricted databases showed that the model output is 
largely affected by the included LET values in the model database, as lowering the 
upper limit of included LET values resulted in a smaller slope in the applied linear 
RBE-LET relationship, indicating a non-linear relationship. Fitting on a balanced 
database in terms of (𝛼 𝛽⁄ )𝑥 largely affected the fitting output. It is however debatable 
whether the applied procedure is optimal, as some of the data points in regions with 
fewer data might be assigned too large weights in the fitting. Non-linear fitting 
generally yielded better performance than linear fitting on the database, although the 
differences were marginal, and a linear dependency could not be rejected. The quartic 
fitting function, 𝑓𝐿𝑄𝐶𝑞, was implied to best model the data, and comparable 
performance was indicated for the fitting functions 𝑓𝐿𝑄, 𝑓𝐿𝑄𝐶 , 𝑓𝐿𝐸 and 𝑓𝐿𝑄𝐸. 
Implementing three of the linear models and the 𝑓𝐿𝑄𝐶𝑞 and 𝑓𝐿𝑄𝐶  models from this work 
in a SOBP scenario, all models gave RBE estimates that largely disagreed with a 
constant RBE=1.1. All the considered models showed only small differences from a 
constant RBE=1.1 in the entrance region. The models deviated more from each other 
at the proximal part of the SOBP, and all models predicted an increasing RBE across 
the SOBP. The RBE increase given by the 𝑓𝐿𝑄𝐶  model was steeper than the other 
models, and although the 𝑓𝐿𝑄𝐶𝑞 model was above this model at the proximal part of the 
SOBP, the 𝑓𝐿𝑄𝐶  model gave higher RBE estimates than the 𝑓𝐿𝑄𝐶𝑞 model at the distal 
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end of the SOBP. The RBE estimates of the linear model obtained with data having all 
values of LET generally gave higher RBE estimates than the two linear models 
obtained with stricter restrictions on both LET and (𝛼 𝛽⁄ )𝑥. The analyses of the present 
work showed that database selection and regression procedure largely affects the 
outcome of RBE modelling. This can explain the observed differences between 
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In 2020 there was 19.3 million new cases of cancer worldwide [1], and 1 in 6 deaths 
were caused by the disease. The main cancer treatment modalities include surgery, 
chemotherapy, immunotherapy and radiotherapy. About 50% of all cancer patients are 
eligible for radiotherapy at some point during the course of disease [2]. The modality 
can be used for curative or palliative treatments. While the latter aims at relieving the 
suffering of patients with non-curable cancer, the goal of curative radiotherapy is to 
kill or inactivate tumor cells while sparing the surrounding healthy tissue. External 
beam therapy was first performed with photon radiation, and this modality have been 
used to treat cancer patients for almost 13 decades. During the 20th century, 
radiotherapy using other particles such as protons, neutrons and electrons has also been 
explored and used for cancer treatment. The maximum dose deposition of protons is in 
the last centimeter of the range, forming the so-called Bragg peak. Protons therefore 
avoid exit doses and greatly reduce the entrance dose compared to photons, providing 
an intrinsic increase in dose conformity.    
1.1 Radiotherapy  
Radiotherapy is one of the most widely used modalities in cancer treatment. Radiation 
treatment with high-energetic photons have dominated the field for the past decades, 
and photon therapy is still the most frequently used modality today. Proton therapy has 
been established as an important radiotherapy modality, as it can offer improved 
sparing of normal tissue compared to conventional radiation therapy with photons. The 
main benefits of proton therapy are seen from the characteristics of the physical dose 
deposition of protons, depicted in Figure 1. While the increasing dose towards the 
tumor volume can provide sparing normal tissue before the target, the finite range of 
the proton beam can ensure little dose deposition beyond the target volume. In addition, 
protons have an increased biological effectiveness compared to photon therapy, 
meaning that protons produce more damage than photons from the same physical dose. 




accounted for in clinical proton therapy by applying a constant RBE-factor of 1.1, thus 
assuming protons to be 10% more efficient than photons.  
 
Figure 1: Depth dose curves for a 200 MeV proton beam: both unmodulated 
and with a 5 cm spread out Bragg peak (SOBP), compared with a 16 MV x-
ray beam. The curves are normalized in each case to 100 at maximum dose. 
(Modified from Mohan and Grosshans [3]) 
More recent clinical and experimental data show that the applied and used constant 
RBE-factor is an oversimplification. An increasing amount of experience and data 
show that the proton RBE varies spatially within the patient, depending on numerous 
factors such as the linear energy transfer (LET), the dose level, physiological and 
biological factors and clinical endpoint [4]. The use of a generic, spatially invariant 
RBE-factor within tumors and normal tissues disregards the evidence of a spatially 
variable RBE. In Figure 2, evidence that the proton RBE varies with depth is shown 
for experimental in vitro data from irradiation of Chinese hamster cells with clinical 





Figure 2: An example of a physical depth dose distribution for protons, found 
by Monte Carlo simulations. The variable RBE value is shown by the points 
and the dashed curve. The lines between the points are only for guidance. As 
seen, the RBE is therefore not constant but increasing with depth in this 
example. Data from in vitro cell irradiation experiments with Chinese hamster 
V79-WNRE cells, extracted from Wouters et al 2015 [5] and Polster et al 2015 
[6]. (Modified from Rørvik et al 2019 [7]) 
Precise modelling of the proton RBE is therefore becoming an important task in order 
to enable better treatment planning and minimize treatment complications in proton 
therapy. Numerous RBE models have been developed over the past decade, aiming to 
account for the potential effects of a variable proton RBE. Most of the published proton 
RBE models are so-called phenomenological models. These are based on empirical 
data from in vitro proton irradiation of various cell lines and utilize the linear-quadratic 
(LQ) model with cell inactivation as a biological endpoint. The LQ model is widely 
used in radiation biology to describe the cell survival as a function of dose based on 
the tissue specific LQ parameters 𝛼 and 𝛽. The modelling has been done using many 
different techniques, databases and endpoints and while a general agreement in RBE 
estimates is seen among most RBE models, there are also clear differences. The present 
uncertainties in the RBE models hampers the introduction of a variable RBE in clinical 




1.2 Project motivation 
Proton RBE models generally predicts that the RBE increases with increasing LET and 
decreasing dose, while it is inversely proportional with the ratio of the tissue specific 
LQ parameters of the reference radiation, (𝛼 𝛽⁄ )𝑥. However, there are still significant 
variations between the estimates of RBE from different models. As the models are 
based on different selections of data it is difficult to draw clear conclusions regarding 
the origin of the observed differences between RBE models, and which models gives 
the best predictions. In addition, new in vitro data has become available over the past 
few years which may contribute to more accurate RBE models.  
The main goal of this project was therefore to use a holistic approach to proton 
RBE modelling by using all available in vitro data and explore how data selection, 
regression methods and model assumptions affect the RBE estimation. With this 
goal, a database containing in vitro proton data from published literature was collected 
and analysed. Data on heavier ions were also included in the database for comparative 
studies and future work. The collected proton data included both data points obtained 
with monoenergetic irradiation and data points obtained using a spread out Bragg peak 
(SOBP), i.e. a proton beam with a wide energy spectrum. The analysis focus on 
investigating the relationships of proton RBE with the type of irradiated tissue and the 
radiation quality of the beam by analysing the proton data in the framework of a 
phenomenological model. The tissue dependency is introduced through the LQ 
parameters of the photon radiation for each respective cell line, while the radiation 
quality is quantified by the LET.  
To achieve the main objective stated above, the following secondary objectives were 
pursued:  
• The RBE for a given averaged LET value might be different for monoenergetic 
and SOBP beam. Although this is a debated issue, it has not been thoroughly 




data only from experiments executed by a pure monoenergetic beam. This study 
therefore aims to identify different trends in RBE data based on experiments 
using monoenergetic irradiation and experiments using an SOBP.  
• The widely used assumption that RBE is inversely proportional with (𝛼 𝛽⁄ )𝑥 
was originally tested on a small dataset [8]. Although many of the published 
RBE models apply this assumption, it’s validity has not been tested in detail on 
a larger and up-to-date dataset. In this study a detailed analysis of the RBEs 
dependency on (𝛼 𝛽⁄ )𝑥 was performed to test this assumption. 
• Most published RBE models assume that the proton RBE is linearly dependent 
on LET. Although some experiments and analyses have indicated a non-linear 
LET dependency [9, 10], this have only to a small degree been explored. The 
present work therefore aims to determine if non-linear RBE models can better 
represent the available in vitro data compared to linear models.  
• Previous models have included data covering different ranges in (𝛼 𝛽⁄ )𝑥 and 
LET. This is likely to affect the RBE estimates and an analysis based on 
different database restrictions in terms of reducing the range of included (𝛼 𝛽⁄ )𝑥 
and LET values was performed with the objective of determining how this will 
affect the model output, potentially explaining differences between previously 









2. Proton therapy 
2.1 Radiation interactions and radiobiology 
2.1.1 Proton interactions with matter 
When protons traverse in matter they interact with the material primarily through three 
processes: inelastic Coulomb scattering, elastic Coulomb scattering and non-elastic 
nuclear reactions [11]. The protons interact with atomic electrons through inelastic 
collisions. This is the main source of proton energy loss. As the proton mass is far 
greater than the electron mass, the proton trajectory is not significantly affected by 
these interactions. The target electron is either excited to a higher energy state or 
ionized, depending on the amount of energy transferred in the collision. If the ionized 
electrons receive a sufficient amount kinetic energy from the initial proton, such 
secondary electrons may cause further ionization in the medium. The energy loss of a 
heavy charged particle is typically referred to as the particles stopping power and is 




















where 𝑑𝐸 is the energy loss over a small distance 𝑑𝑥 given in cm, and the remaining 
variables are described as: 
• 𝑁𝑎 = Avogadro’s number 
• 𝑟𝑒 = classical electron radius 
• 𝑚𝑒 = electron mass 
• 𝑐 = speed of light 
• 𝜌 = density of absorbing material 
• 𝑍 = atomic number of absorbing material 




• 𝑧 = charge of the incident particle 
• 𝛽 = relativistic velocity of the incident particle 
• 𝛾 = Lorentz factor 
• 𝑣 = speed of the incident particle 
• 𝑊𝑚𝑎𝑥 = maximum energy transfer in a single collision 
• 𝐼 = mean excitation potential 
• 𝛿 = density correction factor 
• 𝐶 = shell correction factor 
According to this formula, the stopping power is proportional to the square of the 
incident particle ion charge, while there is no dependence on the mass of the incident 
particle. The stopping power is inversely proportional to the velocity of the incident 
particle, meaning that the heavy ions will deposit most of their energy towards the end 
of their range. The resulting depth dose distribution of heavy ions is thus characterized 
by an exponential increase followed by a sharp dose fall-off, forming the characteristic 
Bragg peak curve which is discussed in more detail in section 2.1.4.  
A proton passing close to an atomic nucleus will experience a repulsive Coulomb force 
resulting from the opposite charges of the proton and the nucleus. Due to the large 
mass of the nucleus, the proton is deflected from its originally straight-line trajectory. 
The proton energy loss from such elastic Coulomb interactions are typically small. 
Although a single scattering normally gives a negligible deflection, the sum of many 
such deflections can be significant. The term multiple Coulomb scattering (MCS) is 
commonly used for the observed effect of countless tiny deflections leading to a lateral 
broadening of the beam. A good implementation of MCS is essential for accurate 
calculation of dose distributions, i.e., in a treatment planning system.  
The protons can also interact through non-elastic nuclear reactions with the atomic 
nucleus. Although they are less frequent, these interactions have a much more 
profound effect in terms of the faith of a single proton [11]. If the distance between 




the projectile proton enters the nucleus, which in turn may emit a proton, deuteron, 
triton or a heavier ion or one or more neutrons. The particles produced in nuclear 
interactions are called secondaries. These particles will contribute to the total dose 
delivered to the patient in a clinical setting. Secondary neutrons might cause dose 
depositions outside the target volume. As they do not carry charge, the neutrons do not 
interact electromagnetically and might travel beyond the range of the primary particles 
[13]. 
The three considered interactions of protons in matter are schematically illustrated in 
Figure 3. In addition to these, proton bremsstrahlung is theoretically possible, but this 
effect is negligible at therapeutic proton beam energies and it will not be considered 
here.  
 
Figure 3: Proton interaction mechanisms: (a) energy loss via inelastic 
Coulomb interaction with atomic electron, (b) deflection of proton trajectory by 
repulsive Coulomb elastic scattering with nucleus, (c) removal of primal proton 
and creation of secondaries via non-elastic nuclear interaction (p=proton, 
e=electron, n=neutron, 𝛾=gamma rays) [11].  
2.1.2 Photon interactions with matter 
Photon interactions are briefly summarized here as the present work revolves around 
the biological effects of protons compared to photons which is the standard radiation 
for radiotherapy. Photons are used as reference radiation in proton cell irradiation 





As a photon beam traverse matter, attenuation of the beam by the absorbing material is 
caused by five major types of interactions: photodisintegration, coherent scattering, the 
photoelectric effect, the Compton effect, and the pair production [14]. The first 
mentioned interaction type is only important at very high photon energies (> 10 MeV) 
and will not be considered here. The other four processes are illustrated in Figure 4. In 
coherent scattering (or Rayleigh scattering), a photon is scattered on an atomic electron. 
No energy is changed into electronic motion and no energy is absorbed in the medium 
in this process. The coherent scattering is probable in high-atomic-number materials 
and with photons of low energy. The process is thus of little importance in radiation 
therapy. The photoelectric effect is a phenomenon in which a photon is absorbed by an 
atom, and as a result one of its orbital electrons is ejected. The kinetic energy of the 
ejected photoelectron is equal to ℎ𝜈 − 𝐸𝐵 , where 𝐸𝐵 is the binding energy of the 
electron. After the ejection of a photoelectron, the atom is left in an excited state. The 
vacancy created in the shell where the ejected electron was positioned can be filled by 
an outer orbital electron with the emission of a characteristic x-ray. There is also the 
possibility of emission of Auger electrons, which will occur when the energy released 
as a result of the outer electron filling the vacancy is given to another electron in a 
higher shell which is subsequently ejected. In the Compton process, the photon 
interacts with an atomic electron as though it were a “free” electron, that is, the binding 
energy of the electron is much less than the energy of the incident photon. In this 
interaction, the electron receives some of the photon energy and is emitted at an angle 
𝜃, while the photon is scattered at an angle 𝜙, with reduced energy. In the process of 
pair production, the photon interacts strongly with the electromagnetic field of an 
atomic nucleus and gives up all its energy in the process of creating a pair consisting 
of an electron and a positron. This process is only possible if the energy of the photon 
is greater than 1.02 MeV, which is the minimum energy required to create the electron-
positron pair given that the rest mass energy of these particles are each equivalent to 





Figure 4: Schematic illustration of photon interaction mechanisms: (a) 
Coherent (Raleigh) scattering, (b) photoelectric effect, (c) Compton effect, (d) 
pair production [14].  
2.1.3 Relative biological effectiveness 
The use of proton therapy in cancer treatment has increased globally over the recent 
decades. The treatment modality can potentially provide a more conformal dose to the 
tumor, sparing more of the surrounding tissue, compared to photon radiation therapy 
[15]. Proton radiation is ionizing, and interacts with the tissue different to photons. 
Thus, the radiation quality for the two modalities is different. Giving the same amount 
of physical dose with photon- and proton therapy, the effect is normally higher for the 
latter. Thus, protons normally produce more biological damage for the same physical 
dose [4]. The potential difference in biological effectiveness must be considered when 
treating patients with different modalities. To acquire this, the relative biological 
effectiveness (RBE) is introduced as a scaling factor to reflect the variations in effect 














where 𝐷𝑥 and 𝐷𝑝 are the absorbed physical doses deposited by the reference photon 
radiation and the proton radiation, respectively.  
There is a lot more gained experience in conventional photon therapy than in proton 
therapy. To utilize this experience in proton therapy, the physical doses must be scaled 
by the proton RBE to account for the difference in biological effectiveness. Today, 
proton therapy treatments are based on a proton RBE of 1.1 relative to high-energy 
photons. However, this generic, spatially invariant factor is only an assumption, 
disregarding the evidence that the proton RBE depends on a number of physical and 
biological factors. Experimental data have shown that the RBE varies with the Linear 
Energy Transfer (LET) (radiation quality?), deposited physical dose and physiological 
and biological properties including cell type, oxygen concentration and clinical 
endpoint [4]. In order to optimize treatment planning and minimize treatment 
complications, a better understanding of the RBE of proton radiation is needed. Over 
the last decades, numerous different RBE models have been developed to account for 
the potential effect of a variable RBE. The models can be divided into three major 
groups: Phenomenological models, plan-based models and mechanical models [16]. 
2.1.4 Depth-dose distributions 
There are distinct differences in the dose depositions of photon and proton radiation. 
By comparing the depth-dose curves for the two radiation modalities in a water 





Figure 5: Depth dose curves for photons, protons and carbon ions, from Monte 
Carlo simulations. The curves represent the absorbed dose and do not take 
into account RBE values. The picture also shows a Spread Out Bragg Peak 
(SOBP) for protons covering a range of 3 cm with a homogeneous dose [13]. 
 
Figure 5 shows depth dose curves for photons, protons and carbon ions and illustrate 
the fundamental difference in dose deposition between photons and ions. The photon 
dose deposition increase with increasing depth up to the maximum dose located a few 
cm inside the phantom. After reaching the depth of maximum dose, the dose deposition 
begins to decrease. As seen in Figure 5, the dose deposition post to the maximum is 
slowly decreasing with depth, compared to the sharp build-up in front of the maximum. 
The depth dose curves for protons are characterized by a relatively low entrance dose. 
At some point of depth, the dose starts to increase exponentially with depth. After 
reaching the depth of maximum dose deposition (the Bragg peak), the curve has a sharp 
fall-off to zero. For both photon- and proton radiation, the depth of the dose maximum 
will depend on the beam energy. This is seen from the two depth dose curves for 
protons in Figure 5, showing that the position of the Bragg peak is a function of the 
primary beam energy. In proton therapy, the energy and intensity of the beam are 
gradually varied to form a series of overlapping Bragg Peaks, adding up to a 




overlapping Bragg peaks is called a Spread Out Bragg Peak (SOBP), illustrated by the 
dashed line in Figure 5. Thus, the depth dose curve for a therapeutic proton beam will 
have an increased entrance dose compared to the depth dose curve for monoenergetic 
protons. This is seen in Figure 5,  where the depth dose curve for the SOBP even has a 
higher entrance dose than the one for photons. The dose deposition for carbon is similar 
to the one for protons, but the carbon curve has a more narrow Bragg beak, and a tail 
of relatively low doses post to the sharp dose fall-off. The tail in the distal end of the 
dose distribution is caused by nuclear fragments from inelastic collisions between the 
carbon ions and the nuclei in the material they traverse.  
The characteristics observed from the (comparison of the) depth-dose curves indicates 
that proton therapy could potentially provide a more conformal irradiation of a tumor, 
and a lower dose to the surrounding healthy tissue, compared to conventional radiation 
therapy. The sharp dose fall-off after the Bragg peak can lower the dose to an organ at 
risk (OAR) positioned near the distal end of a tumor. These favourable qualities of the 
proton dose distribution are the main motivation for application of proton therapy in 
cancer treatment.  
2.1.5 Linear energy transfer 
Even though two different radiation modalities deposit the same physical macroscopic 
dose within the tissue, differences in the ionization density and track structure can cause 
different pattern of dose deposition [16]. This property is described by the radiation 
quality, which is normally quantified by the linear energy transfer (LET) of the 
radiation. The LET describes the rate of energy depositions along the particle track, 





 ,  (2.3) 
where 𝑑𝐸 is the infinitesimal amount of mean energy transferred locally from the 




given in μm. (The LET reflects the biological effectiveness of the radiation. It is not a 
directly measurable quantity, and the experimental equivalent to LET is lineal energy 
(𝑙). ) 
In a clinical setting, the radiation field within the patient consist of multiple types of 
particles with a range of energies, rather than only monoenergetic protons. The 
radiation quality can therefore be described by a dose weighted spectrum from protons 
of different LET values at every spatial location, instead of a single quantity. The dose 
weighted LET spectrum is defined such that the sum of all dose compositions is 
normalized to 1. Each LET entry in the spectrum is weighted by its dose deposition. 
For simplicity, it is most common to describe the spectrum by the dose averaged LET 
value, 𝐿𝐸𝑇𝑑. This is the most commonly reported and applied LET value in radiation 
therapy, both in clinical settings and in radiobiological models.  
 
Figure 6: Depth-Dose and depth-LET curves for a 79.7 MeV monoenergetic 
proton beam. The LET increases slowly up to about one cm before the Bragg 
peak and steeply at points beyond the peak [17]. 
For ion radiation, the 𝐿𝐸𝑇𝑑 is inversely proportional to the beam energy. Thus, for a 
proton beam, the LET is increasing towards the distal end of the beam range, as shown 
in Figure 6. Experimental results show that the RBE increases with increasing LET [4]. 
Therefore, as LET values increase with the depth of the beam, the RBE increases 




depth results in an increased biological dose at greater depths, as illustrated in Figure 
7.  
 
Figure 7: An example of a physical depth dose distribution for a SOBP, from 
Monte Carlo simulations. The biological dose is plotted above the physical 
dose, indicating the higher effectiveness for protons over photons [16]. 
 
The increased RBE at the distal end of the SOBP might cause an increased biological 
dose to OARs located distal to the target volume. In such cases, the biological dose to 
the OARs can be underestimated if a constant RBE of 1.1 is used. As a result, the 
normal tissue complication probability (NTCP) of a patient can increase. To prevent 
the underestimation of biological dose, it is therefore of clinical interest to take the 
variation of RBE along the treatment depth into account in the treatment planning. 
Several RBE models have been developed to predict the biological dose delivered to 
patients [6, 18]. 
2.1.6 Cell survival and the linear-quadratic model 
When a cell is exposed to ionizing radiation, the DNA in the cell nucleus is the main 
target. The damage on the DNA caused by the radiation can be divided into two types, 
single track events and two-track events. A single track event cause a non-repairable 




In RBE experiments, the most common measured endpoint is cell survival of irradiated 
in vitro cells. This is also the basis for most RBE models. Many mathematical models 
have been developed to describe the cell survival curve for tissue under the exposure 
of radiation. The linear-quadratic model (LQ model) is a general radiobiological model 
widely used in radiation biology to describe the cell survival. It can describe the effect 
of radiation on multiple endpoints, and provides a simple relationship between cell 
survival and delivered dose. According to the LQ model, the survival fraction of cells 
(𝑆) after irradiation by a single dose 𝐷 is given by: 
 𝑆(𝐷) = 𝑒−(𝛼𝐷+𝛽𝐷
2),  (2.4) 
where 𝛼 and 𝛽 are the LQ-model fitting parameters describing the dose-response to the 
radiation. The first term in the exponential describes the initial slope of the cell survival 
curve, that is, the linear component caused by single track events. The second term 
describes the quadratic component caused by two-track events. The LQ-parameters are 
found by regression fitting to experimental data. The ratio (𝛼/𝛽) is widely used to 
describe the fractionation sensitivity of different tissue types and organs, as it is 
possible to extract the ratio from clinical endpoints, not only cell survival data [7]. The 
LQ model has been used extensively to analyse and predict response to ionizing 
radiation both in vitro and in vivo [19]. The phenomenological RBE models are 
typically based on the LQ model [20].  
Figure 8 shows the survival curves given by the LQ model for an experiment executed 
with protons and a reference experiment done with photons. The difference in steepness 
between the two curves stems from an RBE above 1. The 𝛼 and 𝛽 parameters are 
different for cell survival experiments executed with protons compared to photons, thus 
giving different cell survival curves. The 𝛼 and 𝛽 data in Figure 8 originates from Belli 




By calculating the ratio of the dose level evaluated at specific survival fraction where 
both modalities are isoeffective, the RBE can be found. This is exemplified in Figure 
8, calculating the RBE for two specific survival fractions.  
 
Figure 8: Schematic dose response curves of V79 hamster cells irradiated 
with monoenergetic protons and with x-rays as reference radiation [16]. 
2.1.7 Coupling the RBE with the LQ-model 
Considering a specific endpoint where proton- and photon irradiation are isoeffective, 
the survival fraction for both modalities are mathematically equal to each other, and 
we can write: 
 𝑆(𝐷𝑝) = 𝑆(𝐷𝑥),  (2.5) 
where 𝑆(𝐷𝑝) and 𝑆(𝐷𝑥) are the survival fractions of proton and photon irradiations, 
respectively. We can describe this equation with the mathematical description of the 
LQ model of the proton and photon irradiation, as given by Equation (2.4): 
 𝑒−(𝛼𝐷𝑝+𝛽𝐷𝑝
2) = 𝑒−(𝛼𝑥𝐷𝑥+𝛽𝑥𝐷𝑥




where 𝐷𝑝 is the physical proton dose, 𝛼 and 𝛽 are the LQ parameters of the proton 
radiation, 𝐷𝑥 is the physical photon dose and 𝛼𝑥 and 𝛽𝑥 are the LQ parameters of the 
photon dose. Solving this equation for 𝐷𝑥 and inserting the result into the definition of 
RBE given in Equation (2.2) yields: 
 





















With this equation, the proton RBE is now only a function of the proton dose and the 
LQ parameters of the proton radiation and the photon reference radiation. Generally, 
the RBE is highest at low doses and decreases with increasing dose, as seen in Figure 
8. By evaluating Equation (2.7) at the upper and lower physical dose limits, we can 
obtain two independent functions describing the extreme RBE at low doses (𝑅𝐵𝐸𝑚𝑎𝑥) 
and high doses (𝑅𝐵𝐸𝑚𝑖𝑛): 













With these two equations, we can now reformulate Equation (2.7) with respect to 
𝑅𝐵𝐸𝑚𝑎𝑥 and 𝑅𝐵𝐸𝑚𝑖𝑛: 
























where (𝛼 𝛽⁄ )𝑥, equivalent to 𝛼𝑥/𝛽𝑥, is the treatment fractionation sensitivity of the 




2.2 RBE modelling 
2.2.1 RBE models in literature 
As mentioned, the RBE models found in literature can be divided into three major 
groups. Phenomenological models try to describe the relationship of measurable 
empirical quantities and do not include any information or assumptions of cells on a 
subcellular level [7]. The majority of proposed RBE models belong to this group of 
models [22]. They rely on measurable input and output variables of cell irradiation 
experiments, typically the 𝐿𝐸𝑇𝑑 and the LQ parameters 𝛼 and 𝛽 of experiments. 
Appropriate assumptions are then made for 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝑅𝐵𝐸𝑚𝑖𝑛 with free fitting 
parameters, which are determined by regression analysis to the data [7]. Most 
phenomenological RBE models employ a linear dependency of 𝐿𝐸𝑇𝑑  to calculate the 
biological dose. However, several experiments have indicated a possible non-linear 
trend [10].  
Plan-based models are not directly based on cell experiments. As the name implies, 
they are instead based on information from treatment plans, like dose and 𝐿𝐸𝑇𝑑 
distributions. For plan-based models it is assumed that he average RBE inside the target 
volume is 1.1, while the definition of 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝑅𝐵𝐸𝑚𝑖𝑛 are linearly dependent of 
𝐿𝐸𝑇𝑑. 
Mechanistic models aim to model the biological effects on a microscopic scale within 
the cells, instead of assuming and calculating relationships between experimental 
variables [7]. The microscopic dose distribution will give rise to biological local events 
within the nucleus, such as double strand breaks (DSB), which are estimated by the 







2.2.2 RBE modelling from the LQ-model 
Phenomenological models are based on empirical data from in vitro proton irradiation 
of various cell lines and utilize the LQ-model with cell inactivation as the biological 
endpoint. All LQ based RBE models have Equation (2.10) in common. They only differ 
by the definitions of the 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝑅𝐵𝐸𝑚𝑖𝑛 functions, which for most models are 
found by regression to an experimental database [22]. The size and selection of the in 
vitro data and the regression technique vary between different models. The models also 
use different assumptions for the 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝑅𝐵𝐸𝑚𝑖𝑛 functions, as they can be made 
dependent on physical quantities like the LET spectrum, the 𝐿𝐸𝑇𝑑 of the beam, or 
biological quantities such as the tissue specific (𝛼 𝛽⁄ )𝑥 ratio of the photon radiation 
[22].  
The RBE is known to vary with tissue type and cell line, and this dependency can be 
taken into consideration in the RBE models. To make a general RBE model which 
include a tissue specific parameter as input to 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝑅𝐵𝐸𝑚𝑖𝑛, the LQ parameters 
of the photon radiation is often used to quantify the tissue type. 
 
Figure 9: Cell survival curves of two different cell lines ((a) SCC25 cells from 
human squamous cell carcinoma of the tongue and (b) DLD1 cells from 
human colorectal tumor), irradiated with 𝐶 
60 𝑜 x-rays. The two arrows in each 
plot show the dose at which the contribution to cell killing is equal for the linear 




axis of both curves, with values (a) 11.333 Gy and (b) 3.083. The 𝛼 and 𝛽 data 
originates from (a) Bettega et al [23] and (b) Baggio et al [24]. 
The LQ model is first and foremost a practical mathematical model for radiation 
response and not necessarily directly related to specific mechanisms. However, one 
idea for the mechanistic justification of the LQ model is that the linear component 
(exp(−𝛼𝐷)) might result from single-track events, while the quadratic component 
(exp(−𝛽𝐷2)) might arise from two-track events . Thus, with this interpretation, the 
first term in the exponential in Equation (2.4) describes unrepairable lethal damage, 
while the second term describes the repairable non-lethal damage. The ratio between 
the LQ parameters (𝛼 𝛽⁄ ) is commonly used to describe the fractionation sensitivity of 
different tissues and organs. The ratio is defined as the dose at which the linear 
contribution to damage equals the quadratic contribution. Figure 9 shows the (𝛼 𝛽⁄ ) 
ratio for two different cell survival curves given by the LQ model. Early responding 
tissues express their damage within a period of days to weeks after irradiation. The 
(𝛼 𝛽⁄ )  ratio of such tissue is in the range 7-20 Gy [25]. For late responding tissues, 
which express their damage months to years after irradiation, the (𝛼 𝛽⁄ )  ratio generally 
ranges from 0.5 to 6 Gy [25]. The dose response of tumor cells are generally thought 
to be similar to that of early responding normal tissues, sometimes with an even higher 
(𝛼 𝛽⁄ ) ratio. However, there are evidence that some human tumor types exhibit low 
(𝛼 𝛽⁄ ) ratios, perhaps even lower than for late normal-tissue reactions [25].  
After the development of an RBE model, the model is typically compared to previous 
published models. An example of such comparison of phenomenological models is 
showed in Figure 10. Here, the two top ranked models from the study by Rørvik et al 
in 2017 [10] (discussed in detail in 2.2.5) are compared to the three established models 
published by Carabe et al [26], Wedenberg et al [8] and McNamara et al [27] by varying 
the 𝐿𝐸𝑇𝑑 and keeping the dose and (𝛼 𝛽⁄ )𝑥 constant at clinical relevant levels. Most of 
the published RBE models consider the 𝑅𝐵𝐸𝑚𝑎𝑥 to be inversely proportional to 
(𝛼 𝛽⁄ )𝑥, as seen in equations (2.11) and (2.15). All the models in Figure 10 are obtained 




values. In the 2017 study by Rørvik et al [10], the reliability of this widely used 
assumption for the dependency on (𝛼 𝛽⁄ )𝑥 is questioned, as it might be too generic. 
Although this tissue dependency has previously been verified and included in many 
phenomenological models, it should potentially be revised in the light of new data and 
new experience. The present study includes an investigation of the validity of this 
assumption when a linear relationship between 𝑅𝐵𝐸𝑚𝑎𝑥 and LET is applied.  
 
Figure 10: The RBE for different 𝐿𝐸𝑇𝑑 values for a monoenergetic beam with 
a physical proton dose of 2 Gy and 4 clinical relevant (𝛼 𝛽⁄ )𝑥 values (Figure 
S4 in the appendix to Rørvik et al 2017 [10]).  
2.2.3 Cell irradiation experiments for proton and ion therapy 
As noted above, the phenomenological RBE models rely on an experimental in vitro 
database. The data is obtained from cell irradiation experiments. The method of such 
experiments is to expose biological samples of specific cell lines to proton radiation 




photons to obtain reference data for the proton RBE determinations. Introduction of 
material into the beam line enables mapping of the biological effect at different points 
on the Bragg curve.  
The results from cell irradiation experiments have been compromised by numerous 
complicating factors such as adequate access to beam time, non-standardized 
irradiations, variations in experimental techniques and reporting, as well as a large span 
of reported biological responses [9]. The methods for mapping spatial variations in 
biological effectiveness have been time-consuming and often yielded inconsistent 
results with large uncertainties [9]. Thus, the data needed to develop accurate RBE 
models have been limited and difficult to obtain.  
In Paganetti’s review from 2014 [4], he systematically analysed hundreds of published 
clonogenic data points [4]. The review highlights the large spread of the existing 
clonogenic data and suggests a need for experimental protocol standardization and 
more complete reporting of fit parameters and errors. This was also addressed by Guan 
et al in 2015 [9], with a report describing their procedure to spatially map the biologic 
effectiveness of scanned proton beams with high accuracy and throughput while 
minimizing biological uncertainties. Their design is summarized below, as an example 
of a possible procedure for cell irradiation experiments: 
Monte Carlo simulations were used to design an apparatus (jig) to attenuate proton 
energy in a stepwise fashion from the incident energy to the end of the range, as 
schematically illustrated in Figure 11a. The basis for this setup is that the LET increases 
as a function of depth along the Bragg curve. 96-well plates were used to allow the 
simultaneous irradiation of biologic samples to multiple dose-LET combinations. The 
wells were grouped into 12 columns, and each of them were simultaneously exposed 
to a different combination of dose and LET, such that all 8 wells in a column were 
intended to receive the same dose-LET combination. The method enables the 
acquisition of 12 times the amount of data from a single exposure. The design can be 




varies from zero to a maximum value, producing protons of increasing LET. The jig 
was custom-fabricated from Lucite and directly mounts into the snout of the scanning 
beam gantry. The biological sample plate is placed on top of the jig with the beam 
directed upwards, as seen in Figure 11b. The thickness of the material interposed in the 
proton beam path varies in increasingly finer increments towards the end of the proton 
range. This was done to increase the resolution in regions of high dose and LET 
gradients.  
 
Figure 11: Design of the irradiation device used by Guan et al [9]. (a) 
Schematic diagram of the jig concept illustrating the strategy for the 
simultaneous irradiation of biological samples in the 96-well plate with protons 
at different depths of the Bragg curve. The grey bars indicate the Lucite, and 
the culture medium is indicated by red. The jig is designed so that the steps 
matches the columns of the 96-well plate, varying the position along the Bragg 
curve. The illustration shows only 9 columns and the step dimensions are not 
to scale. (b) The jig directly mounted onto the scanning beam gantry. The 96-
well plates are inserted into a precisely milled slot in the jig holder designed 
to minimize positioning errors. Protons are incident from below. 
2.2.4 The McNamara model 
In 2015, a phenomenological LQ-based RBE model was proposed by McNamara et al 
[27]. The model was derived using the database from Paganetti’s review in 2014 [4], 
which was the most comprehensive collection of proton RBE experimental data at the 
time. The database consists of 369 data points from 76 different studies. In order to 




applied to the primary dataset. Only data points with 𝐿𝐸𝑇𝑑 < 20 𝑘𝑒𝑉/𝜇𝑚 and 
(𝛼 𝛽⁄ )𝑥 < 30 𝐺𝑦 were used un the fit, excluding 84 data points from the original 
dataset. The LQ model is assumed valid for proton doses ranging from 1-10 𝐺𝑦, so one 
data point only valid for doses between 8-24 𝐺𝑦 was excluded from the dataset. 
Additionally, two other data points were excluded. One of them was considered an 
outlier, the other was reported in the same study, and was removed for the sake of 
consistency. 𝑅𝐵𝐸𝑚𝑎𝑥 were assumed to have a linear relationship with respect to 𝐿𝐸𝑇𝑑 
as well as a dependence on (𝛼 𝛽⁄ )𝑥, while 𝑅𝐵𝐸𝑚𝑖𝑛 was assumed to have a dependence 
on √(𝛼 𝛽⁄ )𝑥, 










𝐿𝐸𝑇𝑑 , (2.12) 
where 𝑝0−3 are the fit parameters for the model. Both assumptions are in accordance 
with the LQ model. The Matlab NonLinearModel.fit algorithm was used to estimate 
the fit parameters using an iterative procedure. The RBE uncertainties calculated from 
Paganetti [4] were used to weight the data in the fitting procedure. To avoid the fitted 
model from extending to the complex plane, three additional data points with 
(𝛼 𝛽⁄ )𝑥~0 were removed from the primary dataset.  
The values of the fit coefficients that best fit the experimental data were found to be: 
𝑝0 = 0.99064 (standard error (SE) 0.014125), 𝑝1 = 0.35605 (SE 0.015038), 𝑝2 =
1.1012 (SE 0.0059972) and 𝑝3 = −0.0038703 (SE 0.00091303). Thus, by putting 
the fit coefficients in Equations (2.11) and (2.12) and inserting the results into Equation 





































The fitted model was thoroughly compared to two previously published LQ based RBE 
models published by Carabe et al in 2012 [26] and Wedenberg et al in 2013 [8], which 
have different assumptions regarding the relationship between LET, 𝛽, 𝛼 and (𝛼 𝛽⁄ )𝑥. 
The Carabe model (CAR model) applies a linear relationship between 𝑅𝐵𝐸𝑚𝑖𝑛, 
𝑅𝐵𝐸𝑚𝑎𝑥 and 𝐿𝐸𝑇𝑑 with a slope depending on (𝛼 𝛽⁄ )𝑥. The Wedenberg model (WED 
model) is based on the assumption that there is a linear relationship between 𝛼 and 
𝐿𝐸𝑇𝑑 with a slope depending on (𝛼 𝛽⁄ )𝑥, while 𝛽 is assumed to be independent of 
𝐿𝐸𝑇𝑑. The predictability of the model was also tested against new experimental RBE 
data published by Guan et al in 2015 [9], after Paganetti’s 2014 review.  
The model comparison and predictability testing using the Guan data are both 
explained in detail in the review concerning the development of the McNamara model 
(MCN model) [27]. While the latter is not considered here, some key results from the 
model comparison are summarized below.  
Predictions of RBE as a function of 𝐿𝐸𝑇𝑑 for different values of (𝛼 𝛽⁄ )𝑥 and a dose of 
2 Gy showed that for all three models, the RBE increases with increasing 𝐿𝐸𝑇𝑑 with a 
somewhat linear relationship between RBE and 𝐿𝐸𝑇𝑑 (especially at large (𝛼 𝛽⁄ )𝑥) and 
a steeper slope occurring at low (𝛼 𝛽⁄ )𝑥. At (𝛼 𝛽⁄ )𝑥 ≲ 5 𝐺𝑦, the MCN model predicts 
RBE values lower than the other two models for 𝐿𝐸𝑇𝑑 ≳ 5 𝑘𝑒𝑉/𝜇𝑚, while it predicts 
slightly higher RBE values at 𝐿𝐸𝑇𝑑 ≲ 5 𝑘𝑒𝑉/𝜇𝑚. For (𝛼 𝛽⁄ )𝑥 ≥ 10 𝐺𝑦, the MCN 
model agrees better with the WED model for low 𝐿𝐸𝑇𝑑 values, while at high 𝐿𝐸𝑇𝑑 it 




The three models were used to predict the RBE for cell survival as a function of (𝛼 𝛽⁄ )𝑥 
for four different 𝐿𝐸𝑇𝑑 values and a dose of 2 Gy, showing that the RBE decreases 
with increasing (𝛼 𝛽⁄ )𝑥 of all three models. The decrease in RBE was most significant 
at low (𝛼 𝛽⁄ )𝑥 values, especially at large 𝐿𝐸𝑇𝑑 values, where the model curves are 
steeper. The MCN model had closer agreement with the WED model, especially at 
𝐿𝐸𝑇𝑑 ≤ 5 𝑘𝑒𝑉/𝜇𝑚. Compared to the two other models, the CAR model predicts 
higher RBE values at (𝛼 𝛽⁄ )𝑥 < 2 𝐺𝑦 and much lower RBE values for (𝛼 𝛽⁄ )𝑥 ≳
5 𝐺𝑦.  
Regarding RBE for cell survival as a function of dose for different (𝛼 𝛽⁄ )𝑥 values and 
an 𝐿𝐸𝑇𝑑 of 2.5 𝑘𝑒𝑉/𝜇𝑚, predictions showed a decreasing RBE with increasing dose 
for (𝛼 𝛽⁄ )𝑥 < 2 𝐺𝑦 for all models. According to the CAR model, RBE increases with 
increasing dose for large (𝛼 𝛽⁄ )𝑥, while the WED model predicts a decrease in RBE 
with increasing dose for all (𝛼 𝛽⁄ )𝑥 values considered. The slope of the MCN model 
converges to zero for high (𝛼 𝛽⁄ )𝑥 values. Overall, the MCN model showed better 
agreement with the CAR model at low (𝛼 𝛽⁄ )𝑥.  
The CAR and WED models are based on fits through a small subset of the data used in 
the fitting of the MCN model. It was also pointed out that all previously published 
phenomenological models were based on limited experimental datasets and they may 
have to be revised [27].  
2.2.5 The Rørvik models 
In 2017, Rørvik et al [10] investigated if biological dose models including non-linear 
LET dependencies should be considered, in contrast to the linear dependency of 𝐿𝐸𝑇𝑑 
employed by most phenomenological models in the calculation of the biological dose. 
To do this, an LET spectrum based dose model was introduced.  
The RBE-LET relationship was investigated by fitting of polynomials from 1st to 5th 
degree to a database of 85 data points from aerobic in vitro experiments. The database 




literature search of more recent articles. Experiments with modulated SOBP or laser 
accelerated protons were excluded, along with extreme LET values above 40 𝑘𝑒𝑉/𝜇𝑚 
and experiments including hypoxic cells. Also excluded from the database were 
experiments with cells having (𝛼 𝛽⁄ )𝑥 above 25 𝐺𝑦 and studies which did not report 
the uncertainties of 𝛼, 𝛼𝑥 and 𝛽𝑥. In addition to this, two experiments with irradiation 
doses exclusively above 8 𝐺𝑦 were excluded because such high dose levels are not 
clinically relevant.  
The polynomials were fitted to the database with both unweighted and weighted 
regression, with the latter taking the experimental uncertainties into account. Statistical 
testing was performed to decide whether higher degree polynomials provided better 
fits to the data compared to lower degrees. A tissue dependent phenomenological 
biological dose model for proton therapy with the full LET spectrum as a parameter for 
the radiation quality was proposed. The model was made tissue and dose dependent by 
Equation (2.10). The dependency on the full dose weighted LET spectrum were 
included by weighting the spectrum with 𝑟𝑚𝑎𝑥(𝐿), which is a biological weighting 
function (BWF) based on data from in vitro cell experiments. The BWF formalism for 
the LET spectrum is then similar to the formalism used in microdosimetric RBE models 
[28]: 
 




The LET spectrum of a monoenergetic proton beam can be expressed as a Dirac delta 
function centered around the  𝐿𝐸𝑇𝑑 of the beam. This property was used to find a 
quantitative description of 𝑟𝑚𝑎𝑥(𝐿), by making a regression fit to a monoenergetic 
database with discrete 𝐿𝐸𝑇𝑑 and corresponding 𝑅𝐵𝐸𝑚𝑎𝑥(𝒅(𝐿)) values. The 
investigation of the RBE-LET relationship through the testing of the fitted polynomials 
aimed to determine the model function of 𝑅𝐵𝐸𝑚𝑎𝑥, while 𝑅𝐵𝐸𝑚𝑖𝑛 was assumed to be 




The result of the statistical testing showed that the linear fit was the most elaborate 
BWF for the unweighted dataset. By using a continuous and linear increasing fit for 
also the high LET region, the 𝑅𝐵𝐸𝑚𝑎𝑥 of the model can be formulated as: 
 




For the weighted dataset, the quartic model was shown to be the best fitting polynomial 
to the data. The model thus needs to be based on the full LET spectrum, and the 
𝑅𝐵𝐸𝑚𝑎𝑥 of the model was formulated as: 
 
𝑅𝐵𝐸𝑚𝑎𝑥(𝒅(𝐿)) = ∫ 𝑟𝑚𝑎𝑥(𝐿)𝒅(𝐿)𝑑𝐿
∞
0
,  (2.16) 






































These two models were compared to three previously published models by 
successively varying the dose, 𝐿𝐸𝑇𝑑 and (𝛼 𝛽⁄ )𝑥 while the other variables were kept 
constant at clinical relevant levels.  
2.2.6 Other RBE models 
In 2018, Rørvik et al [22] published a study in which eleven published 
phenomenological RBE models and two plan-based models were explored. The paper 
provided a list of the dependencies of 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝑅𝐵𝐸𝑚𝑖𝑛 that was applied to develop 
the models, as well as the number of data points and the cell lines that was used to 
derive them. The resulting overview of the considered models in the study by Rørvik 




Table 1: All phenomenological RBE models that was explored by Rørvik [22] listed in 
chronological order according to date of publication. The two plan-based models are given at 
the bottom of the table. The dose-weighted energy spectrum and the dose-weighted LET 
spectrum are denoted by d(E) and d(L), respectively. (Table 1 from Rørvik et al 2018 [22].)  










Belli et al 1997 [29] BEL V-79 6 d(E) d(E) 
Wilkens and Oelfke 2004 [30] WIL V-79 19 LETd 1 
Tilly et al 2005 [31] TIL (TIL2/TIL10) V-79 / 
Multiple 
7 / 4 LETd, (α/β)x 1 
Chen and Ahmad 2012 [32] CHE V-79 14 LETd 1 
Carabe et al 2012 [26] CAR V-79 44 LETd, (α/β)x LETd, (α/β)x 
Wedenberg et al 2013 [8] WED Multiple 19 (24) LETd, (α/β)x 1 
Jones 2015b [33] JON Multiple 28 (200) LETd, αx LETd, βx 
McNamara et al 2015 [27] MCN Multiple 285 LETd, (α/β)x LETd, (α/β)x 
Mairani et al 2017 [34] MAI Multiple 25 (31) LETd, (α/β)x 1 
Rørvik et al 2017 [10] RØR 
(RØRU / RØRW) 
Multiple 85 LETd, (α/β)x / 
d(L), (α/β)x 
1 
Peeler 2016 [35] PLR Multiple 48 LETd, (α/β)x LETd, (α/β)x 
Frese et al 2011 [36] FRE Plan-
based 
0 LETd, αx 1 
Unkelbach et al 2016 [37] UNK Plan-
based 
0 LETd LETd 
The RBE models are developed with experimental databases containing various 
number of datapoints from 6-285, and the range of (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇𝑑 values used to 
derive the models differs considerably [22]. Except from the BEL, WIL, CHE and 
UNK models, all the phenomenological and plan-based models are made tissue 
dependent through the reference radiation parameters of the LQ model. This 
dependency is based on the (𝛼 𝛽⁄ )𝑥 ratio, with the exception of the JON model, which 




The WIL, TIL2, CHE and CAR models are based on proton data from a single cell line, 
yielding a narrow range of (𝛼 𝛽⁄ )𝑥 values. The data used in the TIL10 and PLR models 
and the proton data used in the JON model were obtained with two different cell lines, 
while the remaining models used data from 5 to 33 cell lines, yielding greater ranges 
of (𝛼 𝛽⁄ )𝑥 values. Although the MCN and RØR models include a large number of 
different cell lines, the databases are still dominated by V-79 cells and other Chinese 
hamster cells, which have low (𝛼 𝛽⁄ )𝑥 values. 
As seen in Table 1, all the phenomenological models except from BEL and RØRW use 
𝐿𝐸𝑇𝑑 as a parameter for the radiation quality of the beam. The TIL, CAR, MCN and 
PLR models used data only from 𝐿𝐸𝑇𝑑 values below 20 𝑘𝑒𝑉/𝜇𝑚. This is in line with 
the Paganetti 2014 article [4], which states that 𝐿𝐸𝑇𝑑 values above 20 𝑘𝑒𝑉/𝜇𝑚 are 
rarely present in clinical proton therapy, even for the most extreme cases. While the 
WIL, CAR, MCN and PLR databases are dominated by data points with 𝐿𝐸𝑇𝑑 <
5 𝑘𝑒𝑉/𝜇𝑚, the BEL, TIL, CHE, WED and MAI databases first start at 7.7 𝑘𝑒𝑉/𝜇𝑚, 
showing notable differences between the databases in the low 𝐿𝐸𝑇𝑑 data.  
Regarding the model assumptions used in the regression analysis of 𝑅𝐵𝐸𝑚𝑎𝑥 and 
𝑅𝐵𝐸𝑚𝑖𝑛, all models included a variable 𝑅𝐵𝐸𝑚𝑎𝑥 while BEL, CAR, JON, MCN, PLR 
and UNK were the only ones assuming a variable 𝑅𝐵𝐸𝑚𝑖𝑛. Except from JON, all these 
models have an effective model function for 𝑅𝐵𝐸𝑚𝑖𝑛 that is almost 1 for all (𝛼 𝛽⁄ )𝑥 
and 𝐿𝐸𝑇𝑑 values. As seen in Table 1, the remaining models assume that 𝑅𝐵𝐸𝑚𝑖𝑛 = 1. 
Apart from BEL, CHE, RØRW and PLR, all models are linearly dependent on 𝐿𝐸𝑇𝑑. 
The two last mentioned models assume a non-linear dependency mainly due to the 
inclusion of the cell survival data from Guan et al 2015 [9], which indicated a non-
linear LET dependency. All the models that are made tissue dependent on the LQ 
parameters of the reference radiation assume that 𝑅𝐵𝐸𝑚𝑎𝑥 increases with decreasing 




Fitting of the models to the databases were carried out using unweighted regression 
techniques for the majority of the models. Weighted regression based on the 
uncertainty of the data points is only applied by the MCN and RØRW models.  
In 2016, Mairani et al [38] published a phenomenological LQ based RBE model for 
helium ions in a clinically relevant range of doses. The database used consisted of in 
vitro data points from experiments performed with asynchronous cells, with around 20 
cell lines represented. The coupling of the helium RBE with the LQ model were done 





     ,     𝑅𝛽 ≡
𝛽𝐻𝑒
𝛽𝑥
  (2.18) 
yielding the following helium RBE dependency: 





























Comprehensive data analysis and regression procedures were carried out for the 
parametrization of  𝑅𝐵𝐸𝛼 and 𝑅𝛽. It was assumed that 𝛼𝐻𝑒 approaches 𝛼𝑥 for 
decreasing LET values, and that the initial slope was affected by the cell line via the 
inverse relationship with (𝛼 𝛽⁄ )𝑥, so that the 𝑅𝐵𝐸𝛼 of cell lines with high (𝛼 𝛽⁄ )𝑥was 
less dependent on LET (𝐿), namely: 
 





] ∙ 𝑓(𝐿).  (2.20) 
Several fitting functions were used, with 𝑓(𝐿) of increasing complexity and number of 
parameters, to improve the description of the experimental data until no relevant 
improvements could be found. The procedure used to link experimental 𝑅𝐵𝐸𝛼 data 
with models were based on the Jackknife (JK) resampling technique, which is 




parameters. The dataset was highly inhomogeneous, and 𝛼, 𝛽 and LET were mixed up 
either having experimental uncertainties or not. To deal with this, the JK technique was 
coupled to a data resampling technique which took into account the data uncertainties, 
if available.  
The 𝑅𝛽 ratio showed a large degree of dispersion when plotted against LET, as seen in 
Figure 12. To estimate a trend component in the 𝑅𝛽-𝐿𝐸𝑇(𝐿) relation, a filter was 
applied to the data to remove fluctuating components, yielding an estimate of the slow-
moving trend of the data. A Gaussian filter was adopted for the computation of a 
weighted running average of 𝑅𝛽 ratios. The smoothed 𝑅𝛽 curve was then fitted 
minimizing the unweighted sum of squared differences computed between the 
calculated running mean values and the following parametrization: 
 







Figure 12: Comparison between experimental data (points with error bars), 
weighted running average values (squared connected by a dashed line) and 




Abolfath et al [39] introduced an approach for global fitting of the high-throughput and 
high accuracy clonogenic cell-survival data published by Guan et al [9]. Their 
phenomenological model was based on an extension of the microdosimetric kinetic 
model, originally proposed by Hawkins [40, 41]. Instead of individually fitting cell 
survival curves with measured data for each LET value separately, Abolfath et al [39] 
carried out a global fit to the measured data, aiming to reduce the overall uncertainty. 
The fitting procedure may be more reliable, as it takes into account a correlation among 
the survival curves. The method is based on a three-parameter global fitting. An 
optimization procedure was developed, allowing fitting of a 2D surface in a 3D 
parameter space spanned by dose, LET and cell surviving fraction (SF), using two 
independent variables 𝐷 (macroscopic dose) and 𝐿 (LET as a linear function of the 
dose-averaged lineal energy). Specific forms of polynomials that may be used to fit the 









The result of the global fitting using linear polynomials is shown in Figure 13. In this 
procedure, the LQ parameters are considered 𝛼 = 𝛼0 + 𝛼1𝐿𝐸𝑇 and 𝛽 = 𝛽0 to obtain 





Figure 13: Experimental data of clonogenic cell survival fraction (SF) 
corresponding to H460 (a,b) and H1437 (c,d) cells are shown in blue dots with 
experimental error bars in logarithmic scale. A linear LET model 
corresponding to 𝛼 = 𝛼0 + 𝛼1𝐿 and 𝛽 = 𝛽0 was used to obtain a globally 
optimal surface fitted to the experimental data. The left and right figures show 





3.1 Experimental data 
3.1.1 Collecting the data 
The database was mainly collected from two existing databases. Both of them are 
collections of experimental data from published literature. The first one can be found 
in the appendix (table A1-A4) in Paganetti’s review from 2014 [4]. This database 
contains clonogenic data from proton experiments only. If the data was incompletely 
reported in the original articles, the missing values were found through suitable fits or 
simulations, as explained in detail in the review [4]. The second database used is the 
Particle Irradiation Data Ensemble (PIDE3.1) provided by GSI [42]. The datapoints in 
this database are mainly from irradiation experiments with protons, but it also contains 
data from experiments using other ions, in particular carbon ions. For most of the 
datapoints in the PIDE database, additional values are given for all four LQ-parameters 
𝛼𝑥, 𝛽𝑥, 𝛼 and 𝛽, which reflects fits to the raw data. When collecting the database, if the 
fit-values were provided, they were used instead of the values from the original 
publication with the exception of re-fits giving 𝛼𝑥 = 0. Some datapoints were given in 
both the PIDE- and the Paganetti database, and these datapoints were only included 
once in the database.  
In addition to the datapoints from the Paganetti and the PIDE databases, 24 datapoints 
from the database used by Odin Alvestad in his master-thesis were included [43]. 24 
datapoints from a more recent article by Mara et al [44], that was published after the 
PIDE and Paganetti databases were also included in the database. 
3.1.2 Data selection and filtering 
It was necessary to know the irradiation condition used to obtain the data. That is, 
knowing if a data point is obtained with monoenergetic irradiation or by using an 




monoenergetic data and only SOBP data in order to investigate how RBE is affected 
by the radiation modality used. The PIDE database provides information about the 
irradiation condition for each data point, while no such information is given in the 
Paganetti database. Thus, for the Paganetti data this information had to be found in the 
publications that the data points originated from. If the publication was not accessible, 
or it was not clear from the article which irradiation condition was used to obtain the 
data, the data point were not included in the database. 
Some of the data points had negative values for one or more of the LQ-parameters 𝛼𝑥, 
𝛽𝑥, 𝛼, and 𝛽. These datapoints were excluded from the database, as they were seen as 
less relevant and the inclusion of such data was considered an unnecessary 
overcomplication of the analysis.  
One of the main tasks in the project was to model the RBE based on fitting of 𝑅𝐵𝐸𝑚𝑎𝑥 
(𝛼/𝛼𝑥) values and (𝛼 𝛽⁄ )𝑥 ratios calculated from the data. For datapoints with 𝛼𝑥 = 0, 
the 𝑅𝐵𝐸𝑚𝑎𝑥 cannot be calculated (𝛼/𝛼𝑥 goes to infinity). By the same means, if 𝛽𝑥 =
0, the (𝛼 𝛽⁄ )𝑥 ratio cannot be calculated. Consequently, all data points with one of 
these features were excluded from the database.  
For 35 of the datapoints, the reference radiation were uncertain or not given at all. 18 
of these were from Belli et al 2008 [45], and had both 𝐶 
60 𝑜 and  𝐶 
137 𝑠 given as 
reference radiation. It was decided to use 𝐶 
60 𝑜 as reference radiation for these 
datapoints. The remaining 17 datapoints had no information about the reference 
radiation. This included  2 datapoints from Wulf et al 1985 [46], 2 datapoints from 
Okayasu et al 2006 [47], 7 data points from Cox et al 1977 [48] and 6 data points from 
Kraft et al 1985 [49]. For the former two data points, no information about the reference 
radiation were found in the article, and they were excluded from the database. For the 
remaining 15 data points, the reference radiations were listed as x-rays in the articles, 
without any further specification. It was assumed that 200kVp x-rays are representative 




Two datapoints from proton irradiation experiments were removed due to extreme 
LET-values, associated with large uncertainties. Both of them originated from Belli et 
al 1989 [50]. For proton radiation, the theoretical maximum 𝐿𝐸𝑇𝑑 value of 83𝑘𝑒𝑉/𝜇𝑚. 
One of the data points had 𝐿𝐸𝑇𝑑 = 88.8𝑘𝑒𝑉/𝜇𝑚. This datapoint was thereby excluded 
from the database. The other data point had an 𝐿𝐸𝑇𝑑 value of 63.7𝑘𝑒𝑉/𝜇𝑚. As no 
other datapoints had LET values in this range, it was considered an outlier and 
excluded.  
Three of the proton data points originating form Schuff et al 2002 [51] had very high 
values for 𝑅𝐵𝐸𝑚𝑎𝑥, compared to the rest of the proton data. They had 𝑅𝐵𝐸𝑚𝑎𝑥 values 
of 35.0, 80.0 and 167.5, while the highest value for the remaining data points were 
16.5. The data points were considered as outliers and excluded from the database, as 
they clearly stand out from the others with their deviating values for 𝑅𝐵𝐸𝑚𝑎𝑥.  
3.1.3 Normalizing the 𝐿𝐸𝑇𝑑 
The reported photon reference radiation varies between different experiments. The 
photons used have different energies, thus different LET values. Consequently, the 
reference radiations have an 𝑅𝐵𝐸𝑥 value relative to each other. This has to be 
considered when RBE values are calculated using Equation (2.10) because the 𝛼𝑥 and 
𝛽𝑥 refer to the reference radiation used. For a database consisting of data from multiple 
experiments with multiple endpoints, the 𝑅𝐵𝐸𝑥 for the considered endpoints is 
typically not known. According to Paganetti et al 2014 [4], it is therefore not feasible 
to correct the RBE values deduced from these experiments based on an average 𝑅𝐵𝐸𝑥 
of the reference radiation. Instead, the 𝐿𝐸𝑇𝑑 values can be normalized by calculating 
the relative 𝐿𝐸𝑇𝑑
∗ [4].  
The database is collected from many different experiments, thus reporting a number of 
different photon reference radiations, 20 in total: 𝐶 
137 𝑠 and 𝐶 
60 𝑜 𝛾-rays, 50𝑘𝑉𝑝, 
100𝑘𝑉𝑝, 120𝑘𝑉𝑝, 130𝑘𝑉𝑝, 145𝑘𝑉𝑝, 150𝑘𝑉𝑝, 180𝑘𝑉𝑝, 200𝑘𝑉𝑝, 210𝑘𝑉𝑝, 220𝑘𝑉𝑝, 




photons. The reported 𝐿𝐸𝑇𝑑 values were normalized to the 𝐿𝐸𝑇𝑑 of Cobalt-60 using 
the following equation [10]: 
 𝐿𝐸𝑇∗ = 𝐿𝐸𝑇𝑝 − 𝐿𝐸𝑇𝑥 + 𝐿𝐸𝑇 𝐶 60 𝑜 (3.1) 
where 𝐿𝐸𝑇∗ is the normalized 𝐿𝐸𝑇𝑑 value and 𝐿𝐸𝑇𝑝, 𝐿𝐸𝑇𝑥 and 𝐿𝐸𝑇 𝐶 60 𝑜 are the 𝐿𝐸𝑇𝑑 
values of the proton beam, the photon reference radiation and 𝐶 
60 𝑜, respectively.  
The 𝐿𝐸𝑇𝑥 values were found in the previous published articles by Howard et al 2017 
[52] and Mairani et al 2016 [38]. For the reference radiations in the 𝑘𝑉𝑝 range that 
were not considered in any of these articles, linear interpolation was used to obtain the 
𝐿𝐸𝑇𝑥 value. Only one 𝐿𝐸𝑇𝑥 value were given for reference radiation in the 𝑀𝑉 range, 
that is the value for 6𝑀𝑉 photons from Howard et al 2017 [52]. Thus, there were not 
enough information available to use interpolation here, and the given value for 6𝑀𝑉 
was used for all the reference radiations in the 𝑀𝑉 range. The 𝐿𝐸𝑇𝑥 values used for 
normalization are given in Table 2. 
Table 2: 𝐿𝐸𝑇𝑥 values used to normalize the 𝐿𝐸𝑇𝑑 values of the database. Interpolation was 
used to estimate the values that were not listed. 
Reference radiation 𝐿𝐸𝑇𝑑[𝑘𝑒𝑉/𝜇𝑚] Reference 
𝐶 
137 𝑠 𝛾-rays 0.8 Howard et al 2017 [52] 
6𝑀𝑉 photons 0.2 Howard et al 2017 [52] 
𝐶 
60 𝑜 𝛾-rays 0.4 Mairani et al 2016 [38] 
80𝑘𝑉𝑝 1.549 Mairani et al 2016 [38] 
100𝑘𝑉𝑝  1.443 Mairani et al 2016 [38] 
200𝑘𝑉𝑝  1.164 Mairani et al 2016 [38] 
220𝑘𝑉𝑝  1.127 Mairani et al 2016 [38] 
240𝑘𝑉𝑝  1.092 Mairani et al 2016 [38] 




50𝑘𝑉𝑝 1.708 From interpolation 
120𝑘𝑉𝑝 1.387 From interpolation 
130𝑘𝑉𝑝 1.359 From interpolation 
145𝑘𝑉𝑝 1.317 From interpolation 
150𝑘𝑉𝑝 1.304 From interpolation 
180𝑘𝑉𝑝 1.220 From interpolation 
210𝑘𝑉𝑝 1.145 From interpolation 
225𝑘𝑉𝑝 1.118 From interpolation 
300𝑘𝑉𝑝 0.99 From interpolation 
4𝑀𝑉 0.2 Howard et al 2017 [52] 
10𝑀𝑉 0.2 Howard et al 2017 [52] 
15𝑀𝑉 0.2 Howard et al 2017 [52] 
 
For three of the data points from proton experiments, the calculation of 𝐿𝐸𝑇∗ resulted 
in negative values. This was the case for two data points originating from Matsuura et 
al 2010 [53] and one from Williams et al 1978 [54]. These data points were considered 
as outliers due to the extreme LET values and were therefore excluded from the 
database.  
3.2 RBE modelling 
The methodology described in this section aims to pursue the objectives of the present 
work that were outlined in section 1.2. The proton database was analysed in the 
framework of a phenomenological RBE model to explore how data selection, 






The ranges and distributions of 𝑅𝐵𝐸𝑚𝑎𝑥, 𝐿𝐸𝑇
∗ and (𝛼 𝛽⁄ )𝑥 values in the proton 
database were visualized by histograms, with separate plots for monoenergetic data and 
SOBP data. The proton 𝐿𝐸𝑇∗ were also plotted against the (𝛼 𝛽⁄ )𝑥 values for further 
investigation of the relationship between the distributions of these two variables.  
3.2.2 Linear regression 
Fitting of proton RBE data without database restrictions 
The curve_fit() function provided in the SciPy library in Python was used to obtain fits 
for 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇
∗ and (𝛼 𝛽⁄ )𝑥 for the proton data, applying a linear 
relationship between 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝐿𝐸𝑇
∗. The fitting method, which uses non-linear 
least squares to fit a function to data, was successively applied to all the proton data, 
the monoenergetic proton data and the SOBP proton data. In accordance with the MCN 
model (Equations (2.11), (2.13)) and the Rørvik model obtained with an unweighted 
dataset (RORU model, Equation (2.15)), the intercept at 𝐿𝐸𝑇∗ = 0 𝑘𝑒𝑉/𝜇𝑚 was 
assumed to be equal to 1 for all three fits, and the 𝑅𝐵𝐸𝑚𝑎𝑥 was assumed to be inversely 
proportional with (𝛼 𝛽⁄ )𝑥. The fitting functions were thus assumed to have the form: 
 




where 𝑘 is the fit parameter. In addition to the fit parameters, curve_fit() returns the 
variances of the parameter estimates. These were used to determine the standard 
deviation errors of the obtained 𝑘 values, as explained in the documentation for 
curve_fit() in the SciPy Reference Guide.  
Analysis of RBE dependence on (𝜶 𝜷⁄ )𝒙 
As shown in Equation (3.2), the 𝑅𝐵𝐸𝑚𝑎𝑥 is often assumed to be inversely proportional 
with (𝛼 𝛽⁄ )𝑥. To investigate the validity of this assumption for our proton data, the data 




contained data points with (𝛼 𝛽⁄ )𝑥 values within one of the following intervals (in units 
Gy): [0,3), [3,6), [6,9), [9,12), [12,15), [15,20) and (𝛼 𝛽⁄ )𝑥 ≥ 20. For each subset, 
the ordinary least squares linear regression method LinearRegression() provided in the 
Scikit Learn library in Python was used to obtain fits for the 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ 
relationship. A linear dependency of 𝑅𝐵𝐸𝑚𝑎𝑥 on 𝐿𝐸𝑇
∗ was applied, and the intercept 
was assumed to be equal to 1 for all the fits. In order to investigate a potential 
dependency on the irradiation condition, the fitting procedure was repeated using only 
the monoenergetic data in each subset and using only the SOBP data in each subset.  
The resulting fitted lines were successively compared to the RORU model, the MCN 
model and the fits for 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇
∗ and (𝛼 𝛽⁄ )𝑥 that were previously 
obtained using Equation (3.2).  
Fitting on restricted databases 
Different database restrictions in terms of reduced ranges of included (𝛼 𝛽⁄ )𝑥 and  
𝐿𝐸𝑇∗ values were imposed on the proton data points. The applied combinations of 
restrictions on (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ values are given in Table 3. For each restricted 
database, the curve_fit() function provided in the Scipy library in Python was used to 
obtain fits for 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇
∗ and (𝛼 𝛽⁄ )𝑥 according to the fitting 
function given in Equation (3.2). Separate fitting was done for the monoenergetic data 
and the SOBP data in each of the restricted databases. The resulting fit parameters were 
compared in order to investigate how restrictions on the data used in the fitting affect 
the model output in terms of 𝑅𝐵𝐸𝑚𝑎𝑥 dependencies affecting predictions of 𝑅𝐵𝐸𝑚𝑎𝑥 
values.  
Table 3: Database restrictions on (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ applied to the proton data. The restrictions 
on (𝛼 𝛽⁄ )𝑥 are combined with each of the restrictions on 𝐿𝐸𝑇
∗ given in the same row. 1st to 
4th row: Restrictions on the upper limits of the ranges of included (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ values. 5th 
to 7th row: Restriction on the lower limit of the range of included (𝛼 𝛽⁄ )𝑥 values and restrictions 
on the upper limits of the ranges of included (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ values. 8th to 11th row: 




upper limits of the ranges of included (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ values. 12th to 14th row: Restrictions 
on the upper and lower limits of the ranges of included (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ values.  
(𝛼 𝛽⁄ )𝑥 values [Gy] 𝐿𝐸𝑇
∗ values [𝑘𝑒𝑉/𝜇𝑚] 
All All [0,20) [0,10) [0,5) 
[0,20) All [0,20) [0,10) [0,5) 
[0,10) All [0,20) [0,10) [0,5) 
[0,5) All [0,20) [0,10) [0,5) 
≥ 5 All [0,20) [0,10) [0,5) 
[5,20) All [0,20) [0,10) [0,5) 
[5,10) All [0,20) [0,10) [0,5) 
All ≥ 5 [5,20) [5,10)  
[0,20) ≥ 5 [5,20) [5,10)  
[0,10) ≥ 5 [5,20) [5,10)  
[0,5) ≥ 5 [5,20) [5,10)  
≥ 5 ≥ 5 [5,20) [5,10)  
[5,20) ≥ 5 [5,20) [5,10)  
[5,10) ≥ 5 [5,20) [5,10)  
 
Fitting on balanced databases 
The amount of data points with (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ values in the lower part of the range 
is considerably larger than the number of data points with higher values for (𝛼 𝛽⁄ )𝑥 
and 𝐿𝐸𝑇∗, especially for the SOBP data (as seen in Figure 14 and Figure 15). To take 
this into consideration in the fitting of 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇
∗ and (𝛼 𝛽⁄ )𝑥, 
actions were taken to balance the data used in the fitting.  
To account for the large amount of data points with low (𝛼 𝛽⁄ )𝑥, the proton data points 
with (𝛼 𝛽⁄ )𝑥 < 20 𝐺𝑦 were divided into four subsets, each of them containing data 
points with (𝛼 𝛽⁄ )𝑥 values in the intervals [0,5), [5,10), [10,15) and [15,20), 




randomly chosen data points were used to obtain a fit for 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 
𝐿𝐸𝑇∗ and (𝛼 𝛽⁄ )𝑥 using Equation (3.2). This was repeated 100 times, and the mean 
value of the resulting 100 fit parameters was calculated. Since this mean 𝑘 value is the 
result of many fits using equally many data points with (𝛼 𝛽⁄ )𝑥 values in each of the 
four considered parts of the range [0,20), it is obtained with a more balanced database. 
By the same means, mean 𝑘 values were obtained using only monoenergetic data and 
only SOBP data.  
The same procedure was used to obtain fits to a balanced database with respect to 𝐿𝐸𝑇∗ 
values, using the same intervals, but now in terms of 𝑘𝑒𝑉/𝜇𝑚. It was observed that the 
database contained only three SOBP data points with 𝐿𝐸𝑇∗ values in the interval 
[15,20). In order to obtain at least five SOBP data points in each of the four subsets, 
all proton data with 𝐿𝐸𝑇∗ < 21 𝑘𝑒𝑉/𝜇𝑚 was included in the procedure. Additionally, 
the procedure was carried out for proton data with 𝐿𝐸𝑇∗ < 20 𝑘𝑒𝑉/𝜇𝑚, repeating the 
fitting to 12 randomly chosen data points 165 times so that the total number of data 
points used to obtain the mean fit parameter would be approximately the same as 
before. 
3.2.3 Non-linear regression 
Fitting of proton RBE data without database restrictions 
To explore the appliance of non-linear 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationships, the curve_fit() 
function was used to obtain fits for 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇
∗ and (𝛼 𝛽⁄ )𝑥, using 
different fitting functions of varying complexity. The fitting functions included 
polynomials from 1st to 4th degree, as well as exponential functions. The 𝑅𝐵𝐸𝑚𝑎𝑥 was 
assumed to be inversely proportional with (𝛼 𝛽⁄ )𝑥, and the intercept as assumed to be 
equal to 1. The fitting functions can thus be written 
 







where the multiplicative function 𝑓(𝐿𝐸𝑇∗) take the forms given in Table 4. Each of 
the resulting functions were fitted to all the proton data, only monoenergetic proton 
data and only SOBP proton data. To get an estimate of the goodness of the fits, the 
predictions on 𝑅𝐵𝐸𝑚𝑎𝑥 and the real 𝑅𝐵𝐸𝑚𝑎𝑥 values of the data points were used to 











where 𝑛 is the number of data points, 𝑦(𝑖) is the real 𝑅𝐵𝐸𝑚𝑎𝑥 value associated to the 
𝑖𝑡ℎ set of (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ values 𝒙(𝑖), and 𝑓(𝒙(𝑖)) is the predicted value for this set 
of (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ values. In order to compare the results to the previously obtained 
fits where a linear 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationship was applied, the RMSE of these fits were 
also calculated.  
Table 4: Multiplicative functions inserted into (3.3) to obtain fits for 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 
𝐿𝐸𝑇∗ and (𝛼 𝛽⁄ )𝑥, applying a non-linear relationship between 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝐿𝐸𝑇
∗. 𝑘1-𝑘4 are fit 
parameters to be found in the regression procedure.  
Name Multiplicative function 
𝑓𝐿𝑄 𝑓(𝐿𝐸𝑇∗) = 𝑘1𝐿𝐸𝑇
∗ + 𝑘2𝐿𝐸𝑇
∗2 









𝑓𝑄 𝑓(𝐿𝐸𝑇∗) = 𝑘1𝐿𝐸𝑇
∗2 
𝑓𝑄𝐶  𝑓(𝐿𝐸𝑇∗) = 𝑘1𝐿𝐸𝑇
∗2 + 𝑘2𝐿𝐸𝑇
∗3 








𝑓𝑄𝐸 𝑓(𝐿𝐸𝑇∗) = (𝑘1𝐿𝐸𝑇
∗2) exp(−𝑘2𝐿𝐸𝑇
∗) 







𝑓𝐿𝐸2 𝑓(𝐿𝐸𝑇∗) = (𝑘1𝐿𝐸𝑇
∗) exp(−𝑘2𝐿𝐸𝑇
∗2) 




Fitting on restricted databases 
The non-linear fitting procedure was applied to two different restricted databases. The 
first database included proton data points with (𝛼 𝛽⁄ )𝑥 < 25 𝐺𝑦 and 𝐿𝐸𝑇
∗ <
20 𝑘𝑒𝑉/𝜇𝑚. The second database were obtained with the same restrictions on the 
upper limit of included (𝛼 𝛽⁄ )𝑥 an 𝐿𝐸𝑇
∗ values and an additional restriction on the 
lower limit of included 𝐿𝐸𝑇∗, excluding data points with 𝐿𝐸𝑇∗ < 5 𝑘𝑒𝑉/𝜇𝑚.  
Fitting on balanced databases 
Non-linear fitting on balanced databases in terms of (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ was performed 
by appliance of the same procedure that was previously used to obtain linear fits to 
balanced databases. The procedure was repeated for each of the non-linear fitting 
functions resulting from insertion of the multiplicative functions in Table 4 into 
Equation (3.3), using all proton data, only monoenergetic data and only SOBP data. 
The mean fit parameters from fitting on a balanced database with respect to (𝛼 𝛽⁄ )𝑥 
were obtained from 100 non-linear fits to random samples with 5 data points from each 
subset with (𝛼 𝛽⁄ )𝑥 values in the intervals [0,5), [5,10), [10,15) and [15,20). Fit 
parameters from fitting on a balanced database with respect to 𝐿𝐸𝑇∗ were retrieved by 
the same procedure, using four subsets of data points with 𝐿𝐸𝑇∗ values in each of the 
intervals [0,5), [5,10), [10,15) and [15,21) 
Comparison of non-linear fits with the Rørvik weighted model 
The five non-linear fitting functions that were indicated best suited to model the proton 
data were used to plot 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of LET. In order to compare the non-
linear fits to the similar fitting results from the Rørvik model obtained with a weighted 
database (RORW model), the same relationship was plotted using the 𝑅𝐵𝐸𝑚𝑎𝑥 function 




Application of different models 
To finally compare not only the 𝑅𝐵𝐸𝑚𝑎𝑥 functions, but also the RBE estimates of each 
model, dose, LET and (𝛼 𝛽⁄ )𝑥 dependencies of RBE were quantified using Equation 
(2.10). A selection of the linear and non-linear fits from fitting of 𝑅𝐵𝐸𝑚𝑎𝑥 on databases 
containing both monoenergetic and SOBP data were used to obtain RBE models by 
insertion into Equation (2.10), assuming that 𝑅𝐵𝐸𝑚𝑖𝑛 = 1. The resulting models were 
used to plot estimated RBE values as a function of 𝐿𝐸𝑇∗, dose and (𝛼 𝛽⁄ )𝑥. For each 
of the considered variables, the other two were kept constant at clinically relevant 
levels. The biological doses obtained from three of the linear models, two of the non-
linear models and the RORU, RORW and MCN models were also explored through an 
SOBP scenario. In both the RBE and the biological dose estimates, the considered LET 
values are not given by the normalized LET (𝐿𝐸𝑇∗) relative to the LET of Cobalt-60, 






The database contains 944 data points, 413 of them obtained with proton radiation and 
531 are from irradiation experiments using other ions than protons. The data originates 
from a total of 140 different articles, most of these via the Paganetti and PIDE 
databases. In the following, only the proton data is presented as RBE modelling in this 
work was done using proton data only.  
The proton data included  (𝛼 𝛽⁄ )𝑥 values in the range 0.577 − 114.9 𝐺𝑦, while the 
ranges for the calculated 𝐿𝐸𝑇∗ values and the 𝑅𝐵𝐸𝑚𝑎𝑥 values were 0.251 −
33.2 𝑘𝑒𝑉/𝜇𝑚 and 0 − 16.5, respectively. 148 of the proton data points are obtained 
with monoenergetic radiation. The remaining 265 data points are obtained using SOBP 
beams. The distributions of the (𝛼 𝛽⁄ )𝑥, 𝐿𝐸𝑇
∗, and 𝑅𝐵𝐸𝑚𝑎𝑥 values for the proton data 
points are visualized by the histograms in Figure 14, Figure 15 and Figure 16, with 
separate plots showing the distributions for data points obtained with monoenergetic 
radiation and SOBPs.  
As seen in Figure 14(a), the majority of the proton data points have relatively low 
(𝛼 𝛽⁄ )𝑥 values. There are 334 data points with (𝛼 𝛽⁄ )𝑥 ≤ 10 𝐺𝑦, and 241 of the data 
points have (𝛼 𝛽⁄ )𝑥 ≤ 5 𝐺𝑦. This indicates that the majority of cell irradiation 
experiments are more representative for late responding tissues which are associated 
with low (𝛼 𝛽⁄ )𝑥  values. The histograms in Figure 14(b) and Figure 14(c) shows a 
similar distribution for both the monoenergetic and the SOBP data points, with the 
majority of them having (𝛼 𝛽⁄ )𝑥 values in the lowest part of the range.  
(𝛼 𝛽⁄ )𝑥 values above 20 𝐺𝑦 are unusual and less relevant as they indicate abnormal 
repair mechanisms in the cells. Data with such (𝛼 𝛽⁄ )𝑥 values are often excluded in 
RBE modelling, as the model should represent cells with normal repair mechanisms. 




had values above 20 𝐺𝑦, a split axis was used in the histograms in Figure 14 to 
emphasize the distribution of (𝛼 𝛽⁄ )𝑥 values for the data points with (𝛼 𝛽⁄ )𝑥 ≤ 20 𝐺𝑦. 
The mean 𝐿𝐸𝑇∗ value of the monoenergetic proton data is 11.3 𝑘𝑒𝑉/𝜇𝑚, while the 
SOBP data has a mean 𝐿𝐸𝑇∗ of  3.7 𝑘𝑒𝑉/𝜇𝑚. The distribution of 𝐿𝐸𝑇∗ values in 
Figure 15(a) shows a concentration of data points with values between 0 and 4 Gy, 
with a peak between 1 − 2 𝐺𝑦. 328 of the data points have 𝐿𝐸𝑇∗ ≤ 10 𝑘𝑒𝑉/𝜇𝑚, and 
271 of them are in the interval 0 − 5 𝑘𝑒𝑉/𝜇𝑚. The distribution of 𝐿𝐸𝑇∗ values for 
SOBP proton data in Figure 15(c) shows a very similar distribution to the one in Figure 
15(a), with the largest portion of the data points having values below 5 𝑘𝑒𝑉/𝜇𝑚. 
However, Figure 15(b) shows a different distribution for the monoenergetic data points, 
where the 𝐿𝐸𝑇∗ values are more evenly distributed across the whole range, with a slow 
decreasing trend for increasing 𝐿𝐸𝑇∗. 
From the histograms in Figure 16, we see that almost all the proton data points have 
𝑅𝐵𝐸𝑚𝑎𝑥 values below 5. There are 20 data points with 𝑅𝐵𝐸𝑚𝑎𝑥 > 5, and 17 of them 
are monoenergetic data points. One of the monoenergetic data points stand out from 
the rest, with a high value for 𝑅𝐵𝐸𝑚𝑎𝑥 of 16.5. This data point is a potential outlier, 
and this should be kept in mind when using the database for further work.  
In Figure 17, 𝐿𝐸𝑇∗ is plotted against (𝛼 𝛽⁄ )𝑥 for all proton data points having 
(𝛼 𝛽⁄ )𝑥 ≤ 20 𝐺𝑦 , with separate plots for the monoenergetic and SOBP proton data. 
In Figure 17(a), there are three regions with high density of data points, restricted by 
𝐿𝐸𝑇∗ < 5 𝑘𝑒𝑉/𝜇𝑚 and (𝛼 𝛽⁄ )𝑥 values in the intervals 1 − 2.1 𝐺𝑦, 4 − 5 𝐺𝑦 and 6 −
7 𝐺𝑦. As seen in Figure 17(c), most of the data points in these regions are SOBP data. 
The majority of the SOBP data points have 𝐿𝐸𝑇∗ values in the lower range. Although 
this is seen for all values of (𝛼 𝛽⁄ )𝑥, the variation in 𝐿𝐸𝑇
∗ is higher for the SOBP data 
with (𝛼 𝛽⁄ )𝑥 values in the lower range, compared to the data points with higher (𝛼 𝛽⁄ )𝑥 
values. On the other hand, looking at Figure 17(b), the monoenergetic data points are 




be a tendency of higher 𝐿𝐸𝑇∗ values for higher (𝛼 𝛽⁄ )𝑥, as only one of the 24 
monoenergetic data points with (𝛼 𝛽⁄ )𝑥 > 10 𝐺𝑦 has 𝐿𝐸𝑇





Figure 14: Histograms showing the distribution of (𝛼 𝛽⁄ )𝑥 values for (a) all 
proton data points, (b) proton data points that are obtained with 






Figure 15: Histograms showing the distribution of 𝐿𝐸𝑇∗ values for (a) all proton 
data, (b) proton data obtained with monoenergetic radiation and (c) proton 





Figure 16: Histograms showing the distribution of 𝑅𝐵𝐸𝑚𝑎𝑥 values for (a) all 






Figure 17: Proton 𝐿𝐸𝑇∗ plotted against (𝛼 𝛽⁄ )𝑥 values. In (a), all proton data 
points with (𝛼 𝛽⁄ )𝑥 ≤ 20 𝐺𝑦 are shown. Data points obtained using 
monoenergetic radiation and using an SOBP are shown in (b) and (c) 
respectively, with the same restriction for the (𝛼 𝛽⁄ )𝑥 values as in (a). Similar 






• The proton data covers a wide range of (𝛼 𝛽⁄ )𝑥 values, but most of the data 
points have values indicating cells with normal repair mechanisms. The data is 
not evenly distributed across the (𝛼 𝛽⁄ )𝑥 range, and the database is dominated 
by data points with (𝛼 𝛽⁄ )𝑥 values between 1 − 9 𝐺𝑦.  
• The SOBP data is not evenly distributed over the range of 𝐿𝐸𝑇∗ values, and the 
majority of these data points have 𝐿𝐸𝑇∗ values between 1 − 4 𝑘𝑒𝑉/𝜇𝑚. The 
monoenergetic data have 𝐿𝐸𝑇∗ values that are more spread across the whole 
range, especially in the clinical relevant interval below 20 𝑘𝑒𝑉/𝜇𝑚. The 
different 𝐿𝐸𝑇∗ distributions for monoenergetic and SOBP data are also reflected 
by the mean 𝐿𝐸𝑇∗ values, which are 11.3 𝑘𝑒𝑉/𝜇𝑚 and 3.7 𝑘𝑒𝑉/𝜇𝑚, 
respectively.  
• The database is dominated by proton data points with 𝑅𝐵𝐸𝑚𝑎𝑥 values below 4.  
4.2 Linear regression 
4.2.1 Fitting of proton RBE data without database restrictions 
Fits for 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇
∗ and (𝛼 𝛽⁄ )𝑥 obtained by successively fitting  
Equation (3.2) to all the proton data, the monoenergetic proton data and the SOBP 
proton data are shown in Figure 18(a), (b) and (c), respectively. The general trend was 
similar for all fits, showing increasing 𝑅𝐵𝐸𝑚𝑎𝑥 with increasing 𝐿𝐸𝑇
∗ and decreasing 
𝑅𝐵𝐸𝑚𝑎𝑥 with increasing (𝛼 𝛽⁄ )𝑥. It was observed in section 4.1 that the SOBP data is 
not evenly distributed over the range of 𝐿𝐸𝑇∗ and (𝛼 𝛽⁄ )𝑥 values. This is also seen in 
Figure 18(c), which clearly shows that the database contain very few data points with 
higher values of 𝐿𝐸𝑇∗ in the considered (𝛼 𝛽⁄ )𝑥 interval in the plot. Consequently, 
there are relatively large regions where the fit to SOBP data is based on very few data 
points, which can result in poor modelling in these regions. The resulting model from 




for higher 𝐿𝐸𝑇∗ the model might be less accurate and it should therefore be used with 
caution here.  
By inserting the obtained fit parameters into Equation (3.2), the 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ 
relationships are plotted for six different (𝛼 𝛽⁄ )𝑥 values in Figure 19(a-c). We see that 
the slopes of the lines from the fits to all data (𝑘 = 0.45 ± 0.02) and monoenergetic 
data (𝑘 = 0.45 ± 0.03) are almost equal, while the slope of the line from the fit to 
SOBP data (𝑘 = 0.48 ± 0.03) points is a little steeper. The fit parameters used to 
obtain the plots were not rounded to two decimals, thus the slopes of the lines from the 
fits to all data and monoenergetic data are not equal to each other as implied by the 𝑘 
values given above. 
The fit parameters are very similar with overlapping values considering the estimated 
error. Thus applying a linear relationship between 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝐿𝐸𝑇
∗ with a slope 
inversely dependent on (𝛼 𝛽⁄ )𝑥 show no clear dependency between 𝑅𝐵𝐸𝑚𝑎𝑥 and 
irradiation condition.  
The fit parameters of the RORU model and the MCN model are 𝑘 = 0.65 and 𝑘 =
0.36, respectively. It should be noted that the prior model is derived only from 
monoenergetic proton data, while both monoenergetic and SOBP data was used to 
develop the latter model. The obtained fit parameters lies between the fit parameters of 
the RORU and MCN models, although the difference is larger when comparing to the 
prior model. In Figure 19(d-f), the fit to all proton data is used to plot the 𝑅𝐵𝐸𝑚𝑎𝑥 as a 
function of 𝐿𝐸𝑇∗ for six different (𝛼 𝛽⁄ )𝑥 values, and the same is done using the RORU 
model and the MCN model. For a given 𝐿𝐸𝑇∗ value, the span of 𝑅𝐵𝐸𝑚𝑎𝑥 values 
between two curves plotted with different (𝛼 𝛽⁄ )𝑥 values are widest for the RORU 
model, followed by the fit to all data and the MCN model, respectively. Thus, the 





Figure 18: Fits for 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇
∗ and (𝛼 𝛽⁄ )𝑥, assuming a linear 
relationship between 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝐿𝐸𝑇
∗, intercept equal to 1 and that 𝑅𝐵𝐸𝑚𝑎𝑥 
is inversely proportional with (𝛼 𝛽⁄ )𝑥. The planes are obtained by fitting 
Equation (3.2) to (a) all proton data points, (b) only the monoenergetic proton 
data and (c) the SOBP proton data points. Although all values of (𝛼 𝛽⁄ )𝑥 are 





Figure 19: (a-c): 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇
∗ for different values of (𝛼 𝛽⁄ )𝑥, 
according to the fits to all proton data (blue), monoenergetic proton data (red) 
and SOBP proton data (green) shown in Figure 18(a), (b) and (c), respectively. 
The lines are plotted by inserting the obtained fit parameters and the different 
(𝛼 𝛽⁄ )𝑥 values into Equation (3.2). (d-f): 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇
∗ for 
different (𝛼 𝛽⁄ )𝑥 values, according to the fit to all proton data shown in Figure 
18(a) (blue), the RORU model (Equation (2.15)) (orange) and the MCN model 
(Equation (2.11)) (indigo). The blue lines are obtained by inserting the 
obtained fit parameter and the different (𝛼 𝛽⁄ )𝑥 values into Equation (3.2), and 
the orange and indigo lines are obtained by inserting the different (𝛼 𝛽⁄ )𝑥 





• 𝑅𝐵𝐸𝑚𝑎𝑥 from all, monoenergetic and SOBP data was similar when fitting to 
Equation (3.2) without database restrictions.  
• Although small, a trend could be seen that the fit to SOBP data yielded a steeper 
slope for the 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationship compared to the fit to monoenergetic 
data. This could indicate a dependency on the irradiation condition used, and 
should be further investigated. However, the SOBP data is not evenly distributed 
and modelling to these data is likely to be subject to relatively large uncertainties 
for higher 𝐿𝐸𝑇∗ values. To take this into consideration, a method to obtain fits 
to balanced databases are explored in section 4.2.4.  
• Compared to the RORU model and the MCN model, the fit to all data yielded a 
𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationship for specific values of (𝛼 𝛽⁄ )𝑥 with a smaller slope 
than the prior and a steeper slope than the latter. 
4.2.2 Analysis of RBE dependence on (𝛼 𝛽⁄ )𝑥 
The 𝑘/(𝛼 𝛽⁄ )𝑥 relation that is applied in the regression fits in Figure 18 is a widely 
used assumption for the dependency of 𝑅𝐵𝐸𝑚𝑎𝑥 on (𝛼 𝛽⁄ )𝑥 [22]. For each of the seven 
subsets described in section 3.2.2, an ordinary least square linear regression method 
was used to obtain a fit for the 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationship, as shown in Figure 20. The 
procedure was repeated using only the monoenergetic data and only the SOBP data in 
each subset, as shown in Figure 21 and Figure 22, respectively.  
Now, each of the seven fits in Figure 20, Figure 21 and Figure 22 represents the 
relationship between 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝐿𝐸𝑇
∗ for a specific interval of (𝛼 𝛽⁄ )𝑥 values, 
instead of using (𝛼 𝛽⁄ )𝑥 as a variable. The assumption of a 𝑘/(𝛼 𝛽⁄ )𝑥 relation for the 
dependency of 𝑅𝐵𝐸𝑚𝑎𝑥 on (𝛼 𝛽⁄ )𝑥 is thus not applied in the fits. According to this 
assumption, 𝑅𝐵𝐸𝑚𝑎𝑥 is inversely proportional with (𝛼 𝛽⁄ )𝑥. Thus, if the assumption is 
valid for the data, the regression fit for the subset with lowest (𝛼 𝛽⁄ )𝑥 values should 
have the steepest slope, and the steepness should decrease successively for the subsets 




In Figure 20, we see that the fit to data points with (𝛼 𝛽⁄ )𝑥 values in the interval [0,3) 
has the steepest slope (red line), followed by the fits to proton data having (𝛼 𝛽⁄ )𝑥 
values in [9,12) (light green line), > 20 (pink line), [3,6) (orange line), [12,15) (blue 
line), [6,9) (dark green line), and [15,20) (purple line), respectively. Thus, the data do 
not confirm the assumption that 𝑅𝐵𝐸𝑚𝑎𝑥 is inversely proportional to (𝛼 𝛽⁄ )𝑥. 
However, the red line has the steepest slope, while the smallest slopes belong to the 
purple line. This indicates an overall trend of decreasing slope with increasing (𝛼 𝛽⁄ )𝑥, 
even though the steepness of the fitted lines do not decrease successively for each of 
the following subsets containing data points with higher (𝛼 𝛽⁄ )𝑥 values. The slope of 
the pink line is larger than expected from the assumption. However, the data points 
used to obtain this fit have (𝛼 𝛽⁄ )𝑥 values typical for cells with abnormal repair 
mechanisms and are less relevant in a clinical setting.  
As seen in Figure 20(d), the subset used to obtain the light green line contain one 
datapoint with an 𝑅𝐵𝐸𝑚𝑎𝑥 value that stand out from the other. This data point can 
explain the unexpected steep slope of the fitted line for this subset, as it will affect the 
slope in a positive direction. The pink, orange, blue, dark green and purple lines have 
very similar slopes, all of them within a range of 0.0280. By comparison, the difference 
between the slope of the pink and light green lines is almost four times this range. As 
the experimental uncertainties of the data are not taken into consideration, the fitted 
curves are also associated with these uncertainties. Consequently, the five fits with very 
similar slopes could show more agreement with the assumption of a steeper slope for 
decreasing (𝛼 𝛽⁄ )𝑥 if the experimental uncertainties were taken into account.  
The fits to monoenergetic data in Figure 21 show some of the same properties as the 
fits to all proton data. Again, the fits to the (𝛼 𝛽⁄ )𝑥 intervals [0,3) and [9,12) have the 
steepest slopes, although the latter is the steepest of them. This might be explained by 
the one data point with 𝑅𝐵𝐸𝑚𝑎𝑥 value around 17, which will affect the light green line 
even more this time since there are only four monoenergetic data points with (𝛼 𝛽⁄ )𝑥 




argument about experimental uncertainties will also apply to these fits. Looking away 
from the light green line, the overall trend of decreasing slope with increasing (𝛼 𝛽⁄ )𝑥 
can also be seen for the monoenergetic fits. The light green, blue and pink lines are 
fitted to respectively 4, 5 and 5 data points. This is not a satisfying amount of data, and 
the regression lines will be very sensitive to uncertainties and fluctuations in the small 
subsets they are fitted to.  
 In Figure 22, the fitted line to SOBP data with (𝛼 𝛽⁄ )𝑥 values in the interval [0,3) has 
the steepest slope, followed by the fits to SOBP data having (𝛼 𝛽⁄ )𝑥 values in the 
intervals [3,6), > 20, [6,9), [9,12), [15,20) and [12,15), respectively. As seen in 
Figure 22(e), the last-mentioned fit have a negative slope for 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 
𝐿𝐸𝑇∗. However, it is based on a subset of only 4 data points and can therefore be 
disregarded as an unreliable result. Among the remaining fits, the slope of the pink line 
is the only one contradicting the assumption of a decreasing slope with increasing 
(𝛼 𝛽⁄ )𝑥, as the slope of the other 5 fits are decreasing for each subset with higher 
(𝛼 𝛽⁄ )𝑥 values. However, the slopes of the pink, dark green, light green and purple 
lines are very similar to each other, so both indications and contradictions of the 
(𝛼 𝛽⁄ )𝑥 dependency at issue might be due to experimental uncertainties and 
fluctuations in the data.  
The monoenergetic data point with 𝑅𝐵𝐸𝑚𝑎𝑥 value around 17 which is a potential 
outlier originated from Prise et al 1990 [55]. To investigate how much it influences the 
slopes of the fits in Figure 20(d) and Figure 21(d), this data point was excluded and the 
regression procedure was repeated for the relevant subsets. The resulting fits are shown 
in Figure 23(a) for all proton data and in Figure 23(c) for monoenergetic proton data. 
In Figure 23(b) and Figure 23(d) these new fits for data with (𝛼 𝛽⁄ )𝑥 values in [9,12) 
are plotted together with the previously obtained fits for the other subsets. The slopes 
of the new fits are more in line with the assumption of a decreasing slope with 
increasing (𝛼 𝛽⁄ )𝑥, especially for the new line fitted to the monoenergetic data, which 




[0,3) (red line), as seen in Figure 23(d). The results can thus be interpreted to strengthen 
the suspicion that this data point could be considered an outlier. However, it should be 
kept in mind that the new fit to monoenergetic data with (𝛼 𝛽⁄ )𝑥 values in the interval 





Figure 20: Linear regression fits for 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇
∗ for all proton 
data divided into seven subsets, each containing data points with (𝛼 𝛽⁄ )𝑥 
values in different intervals. The fitted curves for each subset are shown in 





Figure 21: Linear regression fits for 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇
∗ for 
monoenergetic proton data divided into seven subsets, each containing data 
points with (𝛼 𝛽⁄ )𝑥 values in different intervals. The fitted curves for each 






Figure 22: Linear regression fits for 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇
∗ for SOBP 
proton data divided into seven subsets, each containing data points with 
(𝛼 𝛽⁄ )𝑥 values in different intervals. The fitted curves for each subset are 





Figure 23: Linear regression fits for 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇
∗ for proton 
data with 9 𝐺𝑦 ≤ (𝛼 𝛽⁄ )𝑥 < 12 𝐺𝑦, excluding the one data point with higher 
𝑅𝐵𝐸𝑚𝑎𝑥 value. (a): new fit to all proton data points, (b): the new fit to all proton 
data is plotted together with the previously obtained fits for the other six 
subsets, (c): new fit to monoenergetic proton data, (d): the new fit to 
monoenergetic proton data is plotted together with the previously obtained fits 
for the other six subsets.  
The regression fits to all proton data points in Figure 20 are compared to the RORU 
model in Figure 24. The 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationship according to the RORU model 
were plotted for each interval of (𝛼 𝛽⁄ )𝑥 values by putting the mean (𝛼 𝛽⁄ )𝑥 value of 
the data points in each subset into the RORU model obtained with an unweighted 
dataset (Equation (2.15)). Using the same equation, the area between the RORU lines 
corresponding to the upper and lower limits of (𝛼 𝛽⁄ )𝑥 in each of the subsets were 
colored out. In order to do this for the subset with (𝛼 𝛽⁄ )𝑥 values in [0,3), the lower 




clinical relevance. The fits to monoenergetic and SOBP data in Figure 21 and Figure 
22 were also compared to the RORU model in the same way. The figures showing 
these comparisons are given in the Appendix (Figure A2 and Figure A3).  
In Figure 24, we see that only two of the seven linear fits to all proton data lies between 
the upper and lower RORU lines; the fits to data points with (𝛼 𝛽⁄ )𝑥 values in the 
intervals [0,3), and [6,9). For the three subsets with lowest (𝛼 𝛽⁄ )𝑥 values (Figure 
24(a-c)), the fitted lines have smaller slopes than the corresponding RORU lines, while 
for the last four intervals (Figure 24(d-g)) the opposite is true. The slopes of the RORU 
lines thus cover a wider range than the slopes of the fitted lines. All of the RORU lines 
for the mean (𝛼 𝛽⁄ )𝑥 values in each subset are placed with approximately equal 
distance to the RORU lines for the upper and lower (𝛼 𝛽⁄ )𝑥 values in each (𝛼 𝛽⁄ )𝑥 
interval. This indicates that the (𝛼 𝛽⁄ )𝑥 values of the proton data are comparable to the 
(𝛼 𝛽⁄ )𝑥 values of the data points used to develop the RORU model.  
From the comparison between fits to monoenergetic data and the RORU model (Figure 
A2), it was observed that the fit to data points with (𝛼 𝛽⁄ )𝑥 values in the interval [6,9) 
is the only one placed within the colored area. While the fits to monoenergetic data 
with (𝛼 𝛽⁄ )𝑥 values in the intervals [0,3) and [3,6) had smaller slopes than the 
corresponding RORU lines, the rest of the fitted lines to monoenergetic data had 
steeper slopes than the corresponding RORU lines. The comparison between SOBP fits 
and the RORU model (Figure A3) showed that the fit to SOBP data with (𝛼 𝛽⁄ )𝑥 values 
in the interval [0,3) is the only one of the seven fits to SOBP data that lies within the 
colored area defined by the upper and lower RORU lines. The fit to SOBP data points 
with (𝛼 𝛽⁄ )𝑥 ≥ 20 𝐺𝑦  is the only line that has a steeper slope than the corresponding 






Figure 24: Comparison of the linear fits to all proton data (shown in Figure 20) 
and the RORU model. (a)-(g) shows the regression fits (colored lines), the 
RORU lines obtained by putting the mean of the (𝛼 𝛽⁄ )𝑥 values for the data 
points in each interval of (𝛼 𝛽⁄ )𝑥 into Equation (2.15) (black lines) and the area 
spanned by the curves obtained with Equation (2.15) using the upper and 
lower limits for the (𝛼 𝛽⁄ )𝑥 value in each interval (colored area). In (a), the area 
is shown for a lower limit of (𝛼 𝛽⁄ )𝑥 = 1 𝐺𝑦, assuming that clinical use will not 
involve (𝛼 𝛽⁄ )𝑥 values below this. The slope of the RORU lines are also given 
in (a)-(g). The RORU lines and limit areas for each (𝛼 𝛽⁄ )𝑥 interval are potted 




In Figure 25, the fitted lines to all proton data in Figure 20 are compared to the MCN 
model in the same manner as explained for the comparison to the RORU model above. 
The fits to monoenergetic data and SOBP data were also compared to the MCN model, 
and similar figures showing these comparisons are given in the Appendix (Figure A4 
and Figure A5). 
The linear fits to all proton data with (𝛼 𝛽⁄ )𝑥 values in the intervals [0,3) and [3,6) lie 
between the MCN lines for the upper and lower limits in the (𝛼 𝛽⁄ )𝑥 intervals. All the 
fitted lines, except from the fit to data points with (𝛼 𝛽⁄ )𝑥 values in [3,6), have a 
steeper slope than the corresponding MCN lines plotted with the mean (𝛼 𝛽⁄ )𝑥 value 





Figure 25: (a)-(g): The linear fits in Figure 20 for all proton data divided into 
seven subsets are shown (colored lines) together with the MCN lines obtained 
by using the mean (𝛼 𝛽⁄ )𝑥 value for the data points in each subset as an input 
in Equation (2.11) (black lines), The slope of the MCN lines are given in each 
plot. The area between the MCN lines obtained by using the upper and lower 
limits of each (𝛼 𝛽⁄ )𝑥 interval as an input in Equation (2.11) are also shown 
(colored areas). A lower limit of (𝛼 𝛽⁄ )𝑥 = 1 𝐺𝑦 is used in (a), assuming that 
clinical use will not involve (𝛼 𝛽⁄ )𝑥 values below this. The MCN lines and limit 




The linear fits for 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇
∗ for each subset of data points with 
(𝛼 𝛽⁄ )𝑥 values in different intervals shown in Figure 20, Figure 21 and Figure 22 were 
finally compared to the 3D fits for 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇
∗ and (𝛼 𝛽⁄ )𝑥 shown 
in Figure 18. Equation (3.2) was used to plot the 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationship according 
to the 3D fit to all data.  
The linear fits to proton data with (𝛼 𝛽⁄ )𝑥 values in the intervals [0,3), [3,6) and [6,9) 
are inside the respective areas defined by the lines from the 3D fit to all data for the 
upper and lower boundaries in each (𝛼 𝛽⁄ )𝑥 interval, as seen in Figure 26. The linear 
fits to proton data points with (𝛼 𝛽⁄ )𝑥 values in intervals [0,3) and [3,6) have smaller 
slopes than the corresponding lines from the 3D fit to all data. This indicates that the 
𝑅𝐵𝐸𝑚𝑎𝑥 might be overestimated for low (𝛼 𝛽⁄ )𝑥 values and under-estimated for higher 
(𝛼 𝛽⁄ )𝑥 values when 𝑅𝐵𝐸𝑚𝑎𝑥 is assumed to have an inverse proportionality on 
(𝛼 𝛽⁄ )𝑥, compared to the estimated 𝑅𝐵𝐸𝑚𝑎𝑥 values when this assumption is not 
applied. 
Figures showing similar comparisons of linear fits and 3D fits to monoenergetic data 





Figure 26: The linear regression fits to all proton data points from Figure 20 
are shown in (a-g) together with lines obtained from the fitted plane to all data 
from Figure 18(a). These lines are plotted by inserting the obtained fit 
parameter 𝑘 = 0.45 into Equation (3.2) and using the mean (𝛼 𝛽⁄ )𝑥 value of 
the data points in each of the subsets as an input for (𝛼 𝛽⁄ )𝑥 in the equation. 
The slopes of the lines from the 3D fit are given in each plot. The colored area 
in each plot is obtained by using the same equation, and the upper and lower 
boundaries in each interval of (𝛼 𝛽⁄ )𝑥 values. In (h), the lines from the 3D fit 





• Regarding the 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationships from linear regression fits to subsets 
containing proton data with (𝛼 𝛽⁄ )𝑥 values in different intervals, an overall 
agreement with the assumption of an inverse proportionality of 𝑅𝐵𝐸𝑚𝑎𝑥 on 
(𝛼 𝛽⁄ )𝑥 were observed both for the fits to all proton data, and the fits considering 
monoenergetic proton data and SOBP proton data separately. 
• The amount of monoenergetic data used in the analysis is clearly too small to 
get reliable results from the procedure that was applied to investigate the 
(𝛼 𝛽⁄ )𝑥 assumption.  
• The comparison between the fitted lines for the 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationship and 
the 3D fit to all proton data indicated that applying the assumption that 𝑅𝐵𝐸𝑚𝑎𝑥 
is inversely proportional with (𝛼 𝛽⁄ )𝑥 might lead to overestimated 𝑅𝐵𝐸𝑚𝑎𝑥 
values for low (𝛼 𝛽⁄ )𝑥 (≲ 6 𝐺𝑦) and underestimated 𝑅𝐵𝐸𝑚𝑎𝑥 values for higher 
(𝛼 𝛽⁄ )𝑥.  
4.2.3 Fitting on restricted databases 
Equation (3.2) was used to obtain fits for 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇
∗ and (𝛼 𝛽⁄ )𝑥 
using different database restrictions in terms of reduced ranges for 𝐿𝐸𝑇∗ and (𝛼 𝛽⁄ )𝑥. 
For each combination of database restrictions, the resulting fit parameters from 
successive fitting to all the proton data points in question, only the monoenergetic data 
points and only the SOBP data points are given in Figure 27(a), Figure 28(a) and Figure 
29(a). The corresponding standard deviation errors (SDEs) of the fit parameters are 
given in Figure 27(b), Figure 28(b) and Figure 29(b), and the number of data points 
used in each fit are given in Figure 27(c), Figure 28(c) and Figure 29(c).  
The fit parameters in the heatmap in Figure 27(a) are obtained using different 
restrictions on the upper limit of the range of  included (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ values. The 
previous obtained fit parameters from fitting to the unrestricted proton database are 




The heatmap in Figure 27(a) indicates that the restrictions on (𝛼 𝛽⁄ )𝑥 have a relatively 
small impact on the outcome of the fitting. Reducing the upper limit of included 
(𝛼 𝛽⁄ )𝑥 values to 20 𝐺𝑦 and 10 𝐺𝑦 generally resulted in marginal deviations in the 
obtained fit parameters, as most of the 𝑘 values obtained with these (𝛼 𝛽⁄ )𝑥 restrictions 
(row 5-12 in the heatmap) were equal to the ones obtained with no restriction on 
(𝛼 𝛽⁄ )𝑥 and coinciding restrictions on 𝐿𝐸𝑇
∗ (row 1-4 in the heatmap). However, when 
the upper limit of included (𝛼 𝛽⁄ )𝑥 values is reduced to 5 𝐺𝑦, the resulting fit 
parameters (row 13-16 in the heatmap) are generally a little higher than the 
corresponding 𝑘 values obtained with coinciding restrictions on 𝐿𝐸𝑇∗ and higher/no 
restriction on the upper limit of included (𝛼 𝛽⁄ )𝑥 values (row 1-12 in the heatmap).  
While the (𝛼 𝛽⁄ )𝑥 restrictions seem to have a relatively small impact on the outcome 
of the fitting, the heatmap in Figure 27(a) indicates that the restrictions on 𝐿𝐸𝑇∗ affect 
the fit parameters in a more pronounced way. There is a clear trend of decreasing 𝑘 
values for each restriction reducing the range of included 𝐿𝐸𝑇∗ values. This trend is 
observed for all restrictions on (𝛼 𝛽⁄ )𝑥 and both for the fit parameters from the fits to 
all proton data and the fit parameters from the fits to monoenergetic data and SOBP 
data. However, an exception from this trend is observed for the 𝑘 values from fits to 
SOBP data with 𝐿𝐸𝑇∗ < 5 𝑘𝑒𝑉/𝜇𝑚, which are higher than the 𝑘 values from fits to 
SOBP data with 𝐿𝐸𝑇∗ < 10 𝑘𝑒𝑉/𝜇𝑚 for all the applied restrictions on (𝛼 𝛽⁄ )𝑥.  
As the SOBP proton data results from irradiation with a series of overlapping Bragg 
peaks, the 𝐿𝐸𝑇∗ value of each data point actually represent a broad range of 𝐿𝐸𝑇∗ 
values. Consequently, the monoenergetic data are generally more suitable to provide a 





Figure 27: Resulting fit parameters from fitting on restricted databases 
according to Equation (3.2) are visualized by a heatmap (a). For each 
combination of reduced 𝐿𝐸𝑇∗ and (𝛼 𝛽⁄ )𝑥 ranges, the fitting function was 
applied to all the relevant proton data, and separate fits were done for the 
relevant monoenergetic and SOBP data points. Corresponding SDEs 
calculated for each fit value and the number of data points in each of the 
restricted databases are given in the heatmaps in (b) and (c), respectively.  
To obtain the fit parameters in the heatmap in Figure 28(a), a restriction was introduced 
on the lower limit of the range of included (𝛼 𝛽⁄ )𝑥 values. As seen in the figure, proton 
data points with (𝛼 𝛽⁄ )𝑥 < 5 𝐺𝑦 are excluded in all the fits. To investigate the effect 
of this restriction, a comparison of the fit parameters in Figure 28(a) and the fit 
parameters in Figure 27(a) that was obtained using coinciding restrictions on the upper 
limit of the range of included (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ values was carried out. The 




1) The fit parameters in Figure 28(a) cover a wider range than the ones in Figure 
27(a).  
2) The fit parameters in Figure 28(a) from fits to all data and monoenergetic data 
including all 𝐿𝐸𝑇∗ values and 𝐿𝐸𝑇∗ < 20 𝑘𝑒𝑉/𝜇𝑚 are generally higher than 
the corresponding 𝑘 values in Figure 27(a) that was obtained with coinciding 
restrictions on the upper limit of included (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ values.  
3) All of the fit parameters in Figure 28(a) that are obtained using all data points 
and monoenergetic data points with 𝐿𝐸𝑇∗ < 10 𝑘𝑒𝑉/𝜇𝑚 and 𝐿𝐸𝑇∗ <
5 𝑘𝑒𝑉/𝜇𝑚 are lower than the corresponding 𝑘 values in Figure 27(a) that was 
obtained with coinciding restrictions on the upper limit of included (𝛼 𝛽⁄ )𝑥 and 
𝐿𝐸𝑇∗ values.  
4) All fit parameters from fits to SOBP data in Figure 28(a) are lower than the 
corresponding fit parameters from fits to SOBP data using coinciding 
restrictions on the upper limit of the range of included (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ values 
given in Figure 27(a). 
The last mentioned observation shows a clear trend that the fits to SOBP data results 
in lower 𝑘 values when the restriction on the lower limit of the range of included 
(𝛼 𝛽⁄ )𝑥 values is applied. This indicates that an RBE model based on fitting with 
Equation (3.2) on data points having all values of (𝛼 𝛽⁄ )𝑥 might overestimate the RBE 
for high (𝛼 𝛽⁄ )𝑥 values. The outcome of fitting on SOBP data is largely affected by the 
restriction on the lower limit of (𝛼 𝛽⁄ )𝑥, showing that the large amount of SOBP data 
with (𝛼 𝛽⁄ )𝑥 values in this region is dominating in the fitting. To deal with this, a 
method of balancing the database should be applied to prevent the low (𝛼 𝛽⁄ )𝑥 SOBP 
data from playing a too significant role in the fitting.  
The fit parameters in Figure 28(a) indicates that lowering the upper limit of included 
(𝛼 𝛽⁄ )𝑥 values result in a lower 𝑘 value. A clear trend is observed that lowering the 
upper limit of included 𝐿𝐸𝑇∗ values result in lower 𝑘 values. An exception from this 




SOBP data with 𝐿𝐸𝑇∗ < 20 𝑘𝑒𝑉/𝜇𝑚 are lower than the ones obtained from fits to 
SOBP data with 𝐿𝐸𝑇∗ < 10 𝑘𝑒𝑉/𝜇𝑚 for all restrictions on the upper limit of included 
(𝛼 𝛽⁄ )𝑥 values.  
 
Figure 28: Fit parameters from fitting on restricted databases in terms of 
(𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ values are given in the heatmap in (a). The SDEs of the fit 
parameters are given in (b) and the number of data points in the restricted 
databases are given in (c). All the restricted databases are obtained with the 
same restriction on the lower limit in the range of included (𝛼 𝛽⁄ )𝑥 values, as 
data points with (𝛼 𝛽⁄ )𝑥 < 5 𝐺𝑦 are excluded in all fits.  
The fit parameters in the heatmap in Figure 29(a) are all obtained with the same 
restriction on the lower limit of the range of included 𝐿𝐸𝑇∗ values, excluding data 




In contrast to the fit parameters in the heatmap in Figure 28(a), the range of the fit 
parameters obtained with the restriction on the lower limit of included 𝐿𝐸𝑇∗ values are 
similar to the range of the fit parameters in Figure 27(a). Comparing the 𝑘 values in 
Figure 29(a) to the corresponding 𝑘 values obtained with the same restrictions on the 
upper limit of included (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ values in Figure 27(a), three observations 
were done:  
1) Fits to all data using all values of (𝛼 𝛽⁄ )𝑥 and (𝛼 𝛽⁄ )𝑥 < 20 𝐺𝑦 resulted in 
larger 𝑘 values when data points with 𝐿𝐸𝑇∗ < 5 𝐺𝑦 was excluded (although the 
differences are relatively small).  
2) The remaining fit parameters from fits to all data points and monoenergetic data 
were either larger or equal to the corresponding 𝑘 values in Figure 27(a) when 
the restriction on the lower limit of included 𝐿𝐸𝑇∗ values was applied.  
3) A trend is observed for the fit parameters from fits to SOBP data in Figure 29(a) 
that the ones obtained with no restriction on the upper limit of included 𝐿𝐸𝑇∗ 
values and 𝐿𝐸𝑇∗ < 20 𝑘𝑒𝑉/𝜇𝑚 are larger than the corresponding 𝑘 values in 
Figure 27(a), while the fit parameters obtained with 𝐿𝐸𝑇∗ < 10 𝑘𝑒𝑉/𝜇𝑚 are 
smaller than the corresponding ones in Figure 27(a). 
The observed trend of increased 𝑘 values in the fits to data points with 𝐿𝐸𝑇∗ ≥
5 𝑘𝑒𝑉/𝜇𝑚 indicates that the slope of the applied linear 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationship is 
steeper for higher 𝐿𝐸𝑇∗ values. This might imply a non linear trend for this 
relationship.  
From the fit parameters in Figure 29(a), reducing the upper limit of included (𝛼 𝛽⁄ )𝑥 
values seem to have little impact on the outcome of the fitting. Although most of the 𝑘 
values obtained with the same restriction on 𝐿𝐸𝑇∗ are not equal to each other, the 
differences are small, and no clear trend is observed.  
The trend that lowering the upper limit of the range of included 𝐿𝐸𝑇∗ values result in 




SOBP data given in Figure 29(a). However, this trend is not seen for the fit parameters 
from fits to monoenergetic data with 𝐿𝐸𝑇∗ ≥ 5 𝑘𝑒𝑉/𝜇𝑚. These 𝑘 values show several 
indications that no such trend is present, but the most prominent one is the fact that the 
fit parameter obtained with 𝐿𝐸𝑇∗ < 10 𝑘𝑒𝑉/𝜇𝑚 is larger than the one obtained with 
𝐿𝐸𝑇∗ < 20 𝑘𝑒𝑉/𝜇𝑚 for all restrictions on (𝛼 𝛽⁄ )𝑥.  
 
Figure 29: Fit parameters from fitting on restricted databases in terms of 
(𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ values are given in the heatmap in (a). The SDEs of the fit 
parameters are given in (b) and the number of data points in the restricted 
databases are given in (c). All the restricted databases are obtained with the 
same restriction on the lower limit in the range of included 𝐿𝐸𝑇∗ values, as 





In some cases, comparison of fit parameters obtained with coinciding restrictions on 
𝐿𝐸𝑇∗ and different restrictions on the upper limit of included (𝛼 𝛽⁄ )𝑥 values showed 
no clear dependency between the 𝑘 values and the upper limits, while in other cases a 
trend was observed that lowering the upper limit of the range of included (𝛼 𝛽⁄ )𝑥 
values result in lower 𝑘 values. Although no clear overall trend is observed, this might 
indicate that the assumed relationship between 𝑅𝐵𝐸𝑚𝑎𝑥 and (𝛼 𝛽⁄ )𝑥 in the fitting 
function (Equation (3.2)) is not a valid assumption for all values of (𝛼 𝛽⁄ )𝑥. 
As pointed out earlier, the fit parameters in Figure 28(a) obtained with data points 
having (𝛼 𝛽⁄ )𝑥 ≥ 5 𝐺𝑦 show large deviations from the corresponding fit parameters in 
Figure 27(a) obtained with coinciding restrictions on the upper limits of included 
(𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ values. This indicates that the 𝑅𝐵𝐸𝑚𝑎𝑥-(𝛼 𝛽⁄ )𝑥 relationship for the 
proton data points with (𝛼 𝛽⁄ )𝑥 < 5 𝐺𝑦 is different from the relationship for the 
remaining data points. The applied assumption that 𝑅𝐵𝐸𝑚𝑎𝑥 is inversely proportional 
with (𝛼 𝛽⁄ )𝑥 is not in line with this indication, and the need for exploration of other 
assumptions for the 𝑅𝐵𝐸𝑚𝑎𝑥-(𝛼 𝛽⁄ )𝑥 relationship is thus implied.  
Key results 
• Restrictions on (𝛼 𝛽⁄ )𝑥 in terms of reducing the upper limit of the range of 
included (𝛼 𝛽⁄ )𝑥 values had relatively small impact on the outcome of the 
fitting.  
• Reducing the upper limit of the range of included 𝐿𝐸𝑇∗ values shows a clear 
trend of lower 𝑘 values. This trend is repeatedly observed in all the results from 
fitting on restricted databases, indicating a non-linear 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ 
relationship.  
• Excluding data points with (𝛼 𝛽⁄ )𝑥 < 5 𝐺𝑦, a new trend was observed that 
lowering  the upper limit of included (𝛼 𝛽⁄ )𝑥 values result in lower 𝑘 values. It 
was observed that the appliance of this restriction affected the resulting fit 
parameters in a pronounced way, indicating that the 𝑅𝐵𝐸𝑚𝑎𝑥-(𝛼 𝛽⁄ )𝑥 




4.2.4 Fitting on balanced databases 
As seen from the histograms in Figure 14 and Figure 15 in section 4.1, the proton data 
is not evenly distributed over the range of 𝐿𝐸𝑇∗ and (𝛼 𝛽⁄ )𝑥 values, especially the 
SOBP data. This could lead to poor RBE estimation in the ranges of 𝐿𝐸𝑇∗ and (𝛼 𝛽⁄ )𝑥 
with few data points, leading to inaccurate predictions as the fits might over- or 
underestimate the 𝑅𝐵𝐸𝑚𝑎𝑥 in these regions. Results investigating this effect are present 
in the following. The resulting mean fit parameters from fitting to a balanced database 
with respect to (𝛼 𝛽⁄ )𝑥 values and balanced databases with respect to 𝐿𝐸𝑇
∗ values are 
given in the heatmap in Figure 30(a). The fit parameters obtained with imbalanced 
databases containing the data points in the same (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ ranges are given for 
comparison in Figure 30(b).  
The fit parameters from fits to a balanced database in terms of (𝛼 𝛽⁄ )𝑥 shows that the 
large amount of proton data with (𝛼 𝛽⁄ )𝑥 values in the lower range affects the outcome 
of the fitting drastically. Compared to the fit parameters from fitting to imbalanced 
data, the 𝑘 values obtained with fitting to a balanced database using all proton data, 
monoenergetic data and SOBP data are approximately 27% larger, 47% larger and 17% 
smaller, respectively.  
Using a balanced database in terms of 𝐿𝐸𝑇∗, only minor differences were observed for 
the fit parameters from fitting to all data points and monoenergetic data compared to 
the 𝑘 values obtained with imbalanced databases. This is also seen for the fit parameter 
obtained with balanced SOBP data with 𝐿𝐸𝑇∗ < 20 𝑘𝑒𝑉/𝜇𝑚, which is almost equal 
to the corresponding fit parameter obtained with imbalanced data. However, the 𝑘 
value obtained with balanced SOBP data having 𝐿𝐸𝑇∗ < 21 𝑘𝑒𝑉/𝜇𝑚 is larger than the 
corresponding fit parameter obtained with imbalanced SOBP data.  
From the histograms in Figure 15, we see that the SOBP data is imbalanced in terms 
of 𝐿𝐸𝑇∗, while the monoenergetic data have a more uniform distribution of 𝐿𝐸𝑇∗ 




balanced SOBP data in terms of 𝐿𝐸𝑇∗ would deviate more from the ones obtained with 
imbalanced SOBP data, while only small differences were expected in the 𝑘 values 
obtained with balanced and imbalanced monoenergetic data. This was observed from 
the fits to data points with 𝐿𝐸𝑇∗ < 21 𝑘𝑒𝑉/𝜇𝑚, but the fits to data points with 𝐿𝐸𝑇∗ <
20 𝑘𝑒𝑉/𝜇𝑚 did not show this. Given that the database consists of 265 SOBP data 
points and only 148 monoenergetic data points, the imbalanced SOBP data was 
expected to affect the outcome of fitting to all proton data to some extent. Thus, 
comparing the fit parameters from fits to balanced proton data in terms of 𝐿𝐸𝑇∗ and 
the fit parameters obtained with imbalanced proton data, a larger difference than the 
one observed was expected.  
Considering all proton data points and monoenergetic data points, the results from 
fitting on a balanced database in terms of (𝛼 𝛽⁄ )𝑥 indicates that an RBE model based 
on the imbalanced database is likely to underestimate the RBE. However, the results 
form fitting on a balanced SOBP database in terms of (𝛼 𝛽⁄ )𝑥 indicates that the RBE 
might be overestimated if the imbalanced database is used in the modelling. Using a 
balanced database in terms of 𝐿𝐸𝑇∗ seems less critical for the outcome of the 
modelling.  
 
Figure 30: (a): Heatmap showing the fit parameters from fitting on balanced 
databases using Equation (3.2). The 𝑘 values in the first row are mean values 
of the fit parameters from 100 fits on random samples of 20 data points; 5 from 
each subset of data points with (𝛼 𝛽⁄ )𝑥 values in the intervals [0,5), [5,10), 
[10,15) and [15,20). The mean 𝑘 values in the second row are from 100 fits 
on random samples of 20 data points; 5 from each subset of data points with 




fit parameters in the third row are from 165 fits on random samples of 12 data 
points; 3 from each subset of data points with 𝐿𝐸𝑇∗ values in the intervals 
[0,5), [5,10), [10,15) and [15,20). Fit parameters from fitting on imbalanced 
databases with coinciding restrictions on (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ are given in (b) for 
comparison. 
Key results 
• Using a balanced database with respect to (𝛼 𝛽⁄ )𝑥 indicated that the large 
amount of proton data with low (𝛼 𝛽⁄ )𝑥 heavily affects the outcome of the 
fitting. In particular, the results imply that an RBE model based on the 
imbalanced monoenergetic database might underestimate the RBE, while the 
predicted RBE for irradiation with an SOBP might be slightly overestimated.  
• The results from fitting on a balanced database with respect to 𝐿𝐸𝑇∗ showed 
weak indications that an RBE model based on imbalanced data in terms of 𝐿𝐸𝑇∗ 
might predict underestimated RBE values for irradiation with an SOBP.  
4.3 Non-linear regression 
4.3.1 Fitting of proton RBE data without database restrictions 
The multiplicative functions in Table 4 were successively inserted into Equation (3.3) 
to obtain 11 different fitting functions applying a non-linear relationship between 
𝑅𝐵𝐸𝑚𝑎𝑥 and 𝐿𝐸𝑇
∗. These fitting functions were used to obtain fits for 𝑅𝐵𝐸𝑚𝑎𝑥 as a 
function of 𝐿𝐸𝑇∗ and (𝛼 𝛽⁄ )𝑥 using all proton data points, only monoenergetic proton 
data and only SOBP proton data. The resulting fit parameters are given in the heatmaps 
in Figure 31(a), Figure 32(a) and Figure 33(a), respectively. The fit parameter obtained 
with a linear 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationship are given in the first row in each of the 
heatmaps, denoted 𝑓𝐿(𝐿𝐸𝑇
∗). In order to compare the non-linear fits to each other and 
to the linear fit, the RMSE was calculated for each of the obtained fits. The calculated 
RMSE values are given in Figure 31(b), Figure 32(b) and Figure 33(b).  
The fitting results are further visualized in Figure 34, Figure 35 and Figure 36 by plots 
showing 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇




the results from fitting with a linear 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationship are shown in (a) for 
comparison (𝑓𝐿). Proton data points with (𝛼 𝛽⁄ )𝑥 values inside the intervals [0,3), 
[3,6), [6,9), [9,12), [12,15) and [15,20) are plotted in different colours. The non-
linear fits were used to plot 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇
∗ using the (𝛼 𝛽⁄ )𝑥 values in 
the centre of each (𝛼 𝛽⁄ )𝑥 interval, that is 1.5 𝐺𝑦, 4.5 𝐺𝑦, 7.5 𝐺𝑦, 10.5 𝐺𝑦, 13.5 𝐺𝑦 
and 17.5 𝐺𝑦. The curves are plotted in the same colour as the data points in the 
corresponding interval of (𝛼 𝛽⁄ )𝑥 values. 
As seen in Figure 31(b), most of the RMSE values for fits to all proton data are very 
similar to each other, and the lowest value is shared by six of the fits. Most RMSE 
values for the fits to monoenergetic data and SOBP data are also similar to each other, 
as shown in Figure 32(b) and Figure 33(b) respectively. However, it is observed from 
these heatmaps that the fit obtained with 𝑓𝐿𝑄𝐶𝑞  have lowest RMSE value both for the 
monoenergetic data and the SOBP data. This fitting function was also used to obtain 
one of the six fits to all data that had lowest RMSE. Therefore, an overall indication 
that this function yields better fits to the proton data is observed, although the evidence 
supporting this are very weak. This is in agreement with the conclusions from Rørviks 
investigation of the RBE-LET relationship [10]. As seen in Figure 34(d) and Figure 
35(d), the fits to all data and monoenergetic data obtained with 𝑓𝐿𝑄𝐶𝑞  show similar 
qualities when the 𝑅𝐵𝐸𝑚𝑎𝑥 is plotted as a function of 𝐿𝐸𝑇
∗, although the latter has 
more distinct fluctuations in the slope which is most clearly seen from the curve plotted 
with (𝛼 𝛽⁄ )𝑥 = 1.5 𝐺𝑦 in Figure 35(d). From Figure 36(d) it is observed that the curves 
for 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of 𝐿𝐸𝑇
∗ from the corresponding fit to SOBP data has a 
somewhat different shape, as the 𝑅𝐵𝐸𝑚𝑎𝑥 is initially increasing with increasing 𝐿𝐸𝑇
∗ 
and starts to decrease with increasing 𝐿𝐸𝑇∗ at 𝐿𝐸𝑇∗ ≈ 22 𝑘𝑒𝑉/𝜇𝑚. The observed 
differences are also reflected in the fit parameters from fitting with 𝑓𝐿𝑄𝐶𝑞 , as the ones 
obtained with all data and monoenergetic data in Figure 31(a) and Figure 32(a) 
resemble each other, while the fit parameters obtained with SOBP data in Figure 33(a) 




It was observed that four of the fitting functions that resulted in lowest RMSE values 
for all proton data also yielded low RMSE values when they were used to obtain fits to 
monoenergetic data and SOBP data. This was the case for 𝑓𝐿𝑄, 𝑓𝐿𝑄𝐶 , 𝑓𝐿𝐸 and 𝑓𝐿𝑄𝐸, 
which resulted in fits with second lowest RMSE values both in Figure 32(b) and Figure 
33(b). These fitting functions are therefore indicated to be approximately equally good 
as the 4th degree polynomial function. Given the marginally small deviations in RMSE 
values, the results can be interpreted to weakly imply that these five functions might 
generally be better suited to model the data than the other considered functions. As 
these five non-linear functions overall yielded lower RMSE values than the linear fits, 
it is implied that a non-linear 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationship might be favoured.  
 
Figure 31: (a): Fit parameters from fitting on all proton data points, using fitting 
functions resulting form insertion of different multiplicative functions into 
Equation (3.3) to apply different non-linear relationships between 𝑅𝐵𝐸𝑚𝑎𝑥 and 
𝐿𝐸𝑇∗. The previously obtained fit parameter from fitting on all proton data 
applying a linear 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationship is given in the first row in the 





Figure 32: (a): Fit parameters from fitting on monoenergetic proton data, using 
fitting functions resulting form insertion of different multiplicative functions into 
Equation (3.3) to apply different non-linear relationships between 𝑅𝐵𝐸𝑚𝑎𝑥 and 
𝐿𝐸𝑇∗. The previously obtained fit parameter from fitting on monoenergetic 
data applying a linear 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationship is given in the first row in the 





Figure 33: (a): Fit parameters from fitting on SOBP proton data, using fitting 
functions resulting form insertion of different multiplicative functions into 
Equation (3.3) to apply different non-linear relationships between 𝑅𝐵𝐸𝑚𝑎𝑥 and 
𝐿𝐸𝑇∗. The previously obtained fit parameter from fitting on SOBP data 
applying a linear 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationship is given in the first row in the 





Figure 34: (b)-(l): 𝑅𝐵𝐸𝑚𝑎𝑥 plotted as a function of 𝐿𝐸𝑇
∗ for specific values of 
(𝛼 𝛽⁄ )𝑥 using the results from fitting on all proton data points applying different 
non-linear 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationships. The result from appliance of a linear 
relationship between 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝐿𝐸𝑇





Figure 35: (b)-(l): 𝑅𝐵𝐸𝑚𝑎𝑥 plotted as a function of 𝐿𝐸𝑇
∗ for specific values of 
(𝛼 𝛽⁄ )𝑥 using the results from fitting on monoenergetic proton data points 
applying different non-linear 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationships. The result from 
appliance of a linear relationship between 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝐿𝐸𝑇





Figure 36: (b)-(l): 𝑅𝐵𝐸𝑚𝑎𝑥 plotted as a function of 𝐿𝐸𝑇
∗ for specific values of 
(𝛼 𝛽⁄ )𝑥 using the results from fitting on SOBP proton data points applying 
different non-linear 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationships. The result from appliance of 
a linear relationship between 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝐿𝐸𝑇





• Calculated RMSE values were very similar for most of the fits obtained with 
non-linear fitting functions. However, an overall slightly better performance 
was indicated for the fitting functions with the multiplicative functions 𝑓𝐿𝑄, 𝑓𝐿𝑄𝐶 , 
𝑓𝐿𝑄𝐶𝑞, 𝑓𝐿𝐸 and 𝑓𝐿𝑄𝐸, indicating that non-linear fits may give better RBE 
estimation compared to linear fits.  
• The fitting function 𝑓𝐿𝑄𝐶𝑞 gave the overall best performance I terms of RMSE. 
This is in agreement with the conclusions from Rørvik et al 2017 [10], using a 
monoenergetic database.  
4.3.2 Fitting on restricted databases 
The fitting procedure applied in section 4.3.1 was repeated for restricted databases in 
terms of reduced range of included (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ values. The fit parameters in the 
heatmaps in Figure 37(a), Figure 38(a) and Figure 39(a) are obtained with the data 
points that was considered to be of most clinical relevance. According to Paganetti 
2014 [4], 𝐿𝐸𝑇𝑑 values above 20 𝑘𝑒𝑉/𝜇𝑚 are rarely present in clinical proton therapy. 
Therefore, only data points with 𝐿𝐸𝑇∗ < 20 𝑘𝑒𝑉/𝜇𝑚 were included in the fitting. The 
restriction on (𝛼 𝛽⁄ )𝑥 was inspired by the one used to develop the Rørvik models. Only 
data points with (𝛼 𝛽⁄ )𝑥 values indicating cells with normal repair mechanisms were 
included, i.e. (𝛼 𝛽⁄ )𝑥 < 25 𝐺𝑦. In Figure 37(b), Figure 38(b) and Figure 39(b), the 
calculated RMSE values for each of the obtained fits are given.  
As seen in Figure 37(b) and Figure 39(b), the fits to all data and SOBP data obtained 
with the 4th degree polynomial fitting function (𝑓𝐿𝑄𝐶𝑞) have lowest RMSE values. 
Although the difference is not large for the fits to all data, the RMSE for the fit to SOBP 
data obtained with this function show a little larger deviation from the other RMSE 
values in Figure 39(b). The RMSE values for the fits to monoenergetic data weakly 
implies that the fits obtained with 𝑓𝐿𝑄𝐶  and 𝑓𝐿𝑄𝐶𝑞 are better than the other fits. The 




function might yield the best fits to the proton data. This is the same indication as was 
observed from the non-linear fitting on the unrestricted database. However, it seems a 
little stronger in this case, as the RMSE values for the fits obtained with this fitting 
function generally stand more out from the other RMSEs in Figure 37(b), Figure 38(b) 
and Figure 39(b), compared to the RMSE values for fitting on the unrestricted database 
in Figure 31(b), Figure 32(b) and Figure 33(b). It was also observed that the fitting 
functions 𝑓𝐿𝑄, 𝑓𝐿𝑄𝐶 , 𝑓𝐿𝐸  and 𝑓𝐿𝑄𝐸 generally resulted in low RMSE values both for the 
fits to all data points and the fits to monoenergetic and SOBP data. This was also seen 
in the results form non-linear fitting on the unrestricted database, and again indicates 
that these functions are good candidates for non-linear modelling of the data.  
In Figure 40, the fits on the restricted database obtained with the 4th degree polynomial 
fitting function are used to plot the 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationships for the same (𝛼 𝛽⁄ )𝑥 
values as used earlier to visualize the fitting result on the unrestricted database. From 
the figure it is observed that all three fits have similar shapes, as the 𝑅𝐵𝐸𝑚𝑎𝑥 increase 
more rapidly with increasing 𝐿𝐸𝑇∗ up to 𝐿𝐸𝑇∗~16 − 18 𝑘𝑒𝑉/𝜇𝑚, where the curves 
have an extreme and the 𝑅𝐵𝐸𝑚𝑎𝑥 starts decreasing with increasing 𝐿𝐸𝑇
∗. The same 
shape was observed for the 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationship plotted with the fit to the 
unrestricted SOBP data obtained with the same fitting function shown in Figure 36(d). 
However, this is not observed for the corresponding fits to all proton data and 
monoenergetic data in Figure 34(d) and Figure 35(d).  
The fit to SOBP data in Figure 40(c) is based on very few data points with 𝐿𝐸𝑇∗ values 
in the upper part of the considered range and a large amount of low 𝐿𝐸𝑇∗ data. The fit 
should therefore not be trusted, as it is likely to be considerably affected by the 
imbalanced distribution of 𝐿𝐸𝑇∗ values. The fact that the SOBP data is not evenly 
distributed over the range of 𝐿𝐸𝑇∗ values also affects the fit to all data points in Figure 
40(a), as seen from comparison with the fit to monoenergetic data, which has a much 





Figure 37: (a): Fit parameters from fitting on all proton data points in a 
restricted database including the most clinical relevant data. The fits are 
obtained with fitting functions resulting form insertion of different multiplicative 
functions into Equation (3.3) to apply different non-linear relationships 
between 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝐿𝐸𝑇
∗. A linear relationship is also applied, and the 
resulting fit parameters are given in the first row in the heatmap. The 





Figure 38: (a): Fit parameters from fitting on monoenergetic data points in a 
restricted database including the most clinical relevant data. The fits are 
obtained with fitting functions resulting form insertion of different multiplicative 
functions into Equation (3.3) to apply different non-linear relationships 
between 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝐿𝐸𝑇
∗. A linear relationship is also applied, and the 
resulting fit parameters are given in the first row in the heatmap. The 





Figure 39: (a): Fit parameters from fitting on SOBP data points in a restricted 
database including the most clinical relevant data. The fits are obtained with 
fitting functions resulting form insertion of different multiplicative functions into 
Equation (3.3) to apply different non-linear relationships between 𝑅𝐵𝐸𝑚𝑎𝑥 and 
𝐿𝐸𝑇∗. A linear relationship is also applied, and the resulting fit parameters are 
given in the first row in the heatmap. The corresponding RMSEs for each of 





Figure 40: 𝑅𝐵𝐸𝑚𝑎𝑥 plotted as a function of 𝐿𝐸𝑇
∗ for specific values of (𝛼 𝛽⁄ )𝑥 
using the results from fitting on a restricted database applying the 4th degree 
polynomial fitting function. In (a), the fit to all proton data in the database 
restricted by  (𝛼 𝛽⁄ )𝑥 < 25 𝐺𝑦 and 𝐿𝐸𝑇
∗ < 20 𝑘𝑒𝑉/𝜇𝑚 is used, while the fits to 
monoenergetic and SOBP data are used to plot the curves in (b) and (c), 
respectively.  
Non-linear fitting was also performed on a database subject to a restriction on the lower 
limit of included 𝐿𝐸𝑇∗ values. Data points with 𝐿𝐸𝑇∗ < 5 𝑘𝑒𝑉/𝜇𝑚 were excluded 
from the database, while the same restrictions as above was used on the upper limits of 
included (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗ values. Applying quadratic-exponential fitting function, 
𝑓𝑄𝐸, the curve_fit() function raised an error that the least-squares minimization failed. 
The appliance of the fitting functions 𝑓𝐿𝐸2 and 𝑓𝑄𝐸2 also resulted in errors, as the 
curve_fit() function was unable to estimate the covariance of the parameters. These 
three fitting functions were therefore excluded from the fitting procedure. The fit 
parameters and the calculated RMSE values for each of the non-linear fits to all proton 
data in the restricted database, only the monoenergetic data and only the SOBP data 




As seen in the figures, the deviations in RMSE values are very small both for the fits 
to all data and the fits to monoenergetic and SOBP data. In Figure 41(b) the lowest 
RMSE value from fits to all data is shared by two of the fits, while five of the fits to  
monoenergetic data share the lowest RMSE in Figure 42(b), and three of the fits to 
SOBP data share the lowest RMSE value in Figure 43(b). However, the only fit that is 
among the ones having lowest RMSE in all three cases is from fitting with the 4th degree 
polynomial fitting function, which is another weak indication that this might be the best 
fitting function for the data. The fits obtained with 𝑓𝐿𝑄𝐶 , 𝑓𝑄𝐶 , 𝑓𝑄𝐶𝑞 and 𝑓𝐿𝑄𝐸 had low 
RMSE values both for all proton data points and monoenergetic and SOBP data, 
indicating that these functions are reasonable candidates to be considered for non-linear 
fitting of proton RBE data.  
 
Figure 41: (a): Fit parameters from fitting on all proton data points in a 
restricted database including data with (𝛼 𝛽⁄ )𝑥 < 25 𝐺𝑦 and 𝐿𝐸𝑇
∗ values in 
the interval [5,20) (given in 𝑘𝑒𝑉/𝜇𝑚). The fits are obtained with fitting functions 
resulting form insertion of different multiplicative functions into Equation (3.3) 
to apply different non-linear relationships between 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝐿𝐸𝑇
∗. A linear 
relationship is also applied, and the resulting fit parameters are given in the 
first row in the heatmap. The corresponding RMSEs for each of the fits are 





Figure 42: (a): Fit parameters from fitting on the monoenergetic data points in 
a restricted database including data with (𝛼 𝛽⁄ )𝑥 < 25 𝐺𝑦 and 𝐿𝐸𝑇
∗ values in 
the interval [5,20) (given in 𝑘𝑒𝑉/𝜇𝑚). The fits are obtained with fitting functions 
resulting form insertion of different multiplicative functions into Equation (3.3) 
to apply different non-linear relationships between 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝐿𝐸𝑇
∗. A linear 
relationship is also applied, and the resulting fit parameters are given in the 
first row in the heatmap. The corresponding RMSEs for each of the fits are 





Figure 43: (a): Fit parameters from fitting on the SOBP data points in a 
restricted database including data with (𝛼 𝛽⁄ )𝑥 < 25 𝐺𝑦 and 𝐿𝐸𝑇
∗ values in 
the interval [5,20) (given in 𝑘𝑒𝑉/𝜇𝑚). The fits are obtained with fitting functions 
resulting form insertion of different multiplicative functions into Equation (3.3) 
to apply different non-linear relationships between 𝑅𝐵𝐸𝑚𝑎𝑥 and 𝐿𝐸𝑇
∗. A linear 
relationship is also applied, and the resulting fit parameters are given in the 
first row in the heatmap. The corresponding RMSEs for each of the fits are 
given in (b). 
Key results 
• Fitting on restricted databases show the same results as fitting on the 
unrestricted database,  indicating that the appliance of 𝑓𝐿𝑄𝐶𝑞 yielded the best fits 
when comparing the calculated RMSE values. Several non-linear fitting 
functions were indicated to be better suited to model the data than the linear 
fitting function, according to the RMSE values.  
• The RMSE values for the  fits to proton data with (𝛼 𝛽⁄ )𝑥 < 25 𝐺𝑦 and 𝐿𝐸𝑇
∗ <
20 𝑘𝑒𝑉/𝜇𝑚 indicated that 𝑓𝐿𝑄, 𝑓𝐿𝑄𝐶 , 𝑓𝐿𝐸 and 𝑓𝐿𝑄𝐸 are also good candidates to 
model the proton data.  
• Applying an additional restriction on the lower limit of included 𝐿𝐸𝑇∗ values, 




resulting fits indicated that 𝑓𝐿𝑄𝐶 , 𝑓𝑄𝐶 , 𝑓𝑄𝐶𝑞 and 𝑓𝐿𝑄𝐸 are the most promising 
model candidates, in addition to 𝑓𝐿𝑄𝐶𝑞.  
4.3.3 Fitting on balanced databases 
The polynomial functions in the first seven rows in Table 4 was inserted into Equation 
(3.3) and the resulting fitting functions was used to obtain fits on balanced databases 
with respect to (𝛼 𝛽⁄ )𝑥 and 𝐿𝐸𝑇
∗. The fitting was carried out using the same procedure 
and intervals as in section 3.2.2 to obtain mean fit parameters from 100 fits on random 
samples.  
The resulting mean 𝑘 values from appliance of this procedure to all data points with 
(𝛼 𝛽⁄ )𝑥 < 20 𝐺𝑦 are given in Figure 44(a), while only the monoenergetic data and 
only the SOBP data was used to obtain the mean 𝑘 values in Figure 45(a) and Figure 
46(a), respectively. The RMSE values of the resulting fits are given in (b) in each 
figure. The fits obtained with a corresponding imbalanced database are given in (c) in 
each figure, and the RMSE values of these fits are given in (d) in each figure.  
It is clear from the figures that the appliance of a balanced database with respect to 
(𝛼 𝛽⁄ )𝑥 largely affects the fitting outcome, as most of the fit parameters show relatively 
large deviations from the corresponding ones obtained with an imbalanced database. 
The RMSE values indicate that the linear fitting function is best suited for fitting on 
the balanced database both when all proton data are used in the fitting and when  
monoenergetic and SOBP data are treated separately. Fitting on the balanced database 
using the 4th degree polynomial fitting function, which was previously indicated to be 
the most promising candidate for non-linear fitting, result in fits having high RMSE 
values. The large deviations between the results from fitting on balanced- and 
imbalanced databases with respect to (𝛼 𝛽⁄ )𝑥 indicates that the larger portion of data 
points with low (𝛼 𝛽⁄ )𝑥 values have a pronounced effect on the outcome of non-linear 
fitting. However, when performing non-linear fitting, it might not be necessary to 




more suited to handle variable amounts of data points in different regions. With the 
applied procedure to obtain balanced databases, the data points with (𝛼 𝛽⁄ )𝑥 values in 
the interval [15,20) will be more weighted in the fitting, as there are fewer data points 
in this interval. Therefore, balancing the database might actually have a bad impact on 
the fitting outcome, as some datapoints can be assigned unreasonable large weights. 
The large deviations observed might thus be connected to this effect, and are not 
necessarily caused by the larger portion of data points with low (𝛼 𝛽⁄ )𝑥 values alone.  
 
Figure 44: (a): Fit parameters from non-linear fitting on all proton data points 
in a balanced database with respect to (𝛼 𝛽⁄ )𝑥. The corresponding RMSE 
values for each resulting fit is given in (b). In (c), fit parameters from fitting on 
all proton data points in the corresponding imbalanced database are given for 
comparison, and the RMSE values for these fits are given in (d).  
 
Figure 45: (a): Fit parameters from non-linear fitting on monoenergetic proton 
data points in a balanced database with respect to (𝛼 𝛽⁄ )𝑥. The corresponding 




fitting on monoenergetic proton data points in the corresponding imbalanced 
database are given for comparison, and the RMSE values for these fits are 
given in (d). 
 
Figure 46: (a): Fit parameters from non-linear fitting on SOBP proton data points in a 
balanced database with respect to (𝛼 𝛽⁄ )𝑥. The corresponding RMSE values for each 
resulting fit is given in (b). In (c), fit parameters from fitting on SOBP proton data points in 
the corresponding imbalanced database are given for comparison, and the RMSE values 
for these fits are given in (d). 
The fit parameters from non-linear fitting on balanced databases with respect to 𝐿𝐸𝑇∗ 
using all proton data with 𝐿𝐸𝑇∗ < 21 𝑘𝑒𝑉/𝜇𝑚 are given in Figure 47(a), and the fit 
parameters obtained using monoenergetic data and SOBP data are given in Figure 48(a) 
and Figure 49(a), respectively. To get an estimate of the goodness of the fits, RMSE 
values were calculated and are given in (b) in each figure. The fit parameters from 
fitting on the corresponding imbalanced database, and the RMSEs of these fits are 
given in respectively (c) and (d) in each figure.  
From Figure 47(a) Figure 48(a) and Figure 49(a), it is observed that the fit parameters 
from non-linear fitting on the balanced database are similar or equal to the 
corresponding fit parameters obtained with an imbalanced database. Consequently, 
very small deviations are seen between the RMSE values for corresponding fits to the 
balanced and imbalanced databases. This indicates that the outcome of non-linear 
fitting on the proton data is insignificantly influenced by the fact that the SOBP proton 
data is not evenly distributed over the range of 𝐿𝐸𝑇∗ values. However, from Figure 49 




large RMSE compared to the corresponding fit to imbalanced SOBP data. This is worth 
noting, as it does not support the indications in previous results from non-linear fitting 
that 𝑓𝐿𝑄𝐶𝑞 might be the best candidate to model the data. 
 
Figure 47: (a): Fit parameters from non-linear fitting on all proton data points 
in a balanced database with respect to 𝐿𝐸𝑇∗. The corresponding RMSE 
values for each resulting fit is given in (b). In (c), fit parameters from fitting on 
all proton data points in the corresponding imbalanced database are given for 
comparison, and the RMSE values for these fits are given in (d). 
 
Figure 48: (a): Fit parameters from non-linear fitting on monoenergetic proton 
data points in a balanced database with respect to 𝐿𝐸𝑇∗. The corresponding 
RMSE values for each resulting fit is given in (b). In (c), fit parameters from 
fitting on monoenergetic proton data points in the corresponding imbalanced 
database are given for comparison, and the RMSE values for these fits are 





Figure 49: (a): Fit parameters from non-linear fitting on SOBP proton data 
points in a balanced database with respect to 𝐿𝐸𝑇∗. The corresponding RMSE 
values for each resulting fit is given in (b). In (c), fit parameters from fitting on 
SOBP proton data points in the corresponding imbalanced database are given 
for comparison, and the RMSE values for these fits are given in (d). 
Key results 
• The fitting outcome is heavily affected when a balanced database with respect 
to (𝛼 𝛽⁄ )𝑥 is used in the fitting, and the RMSE values of the fits indicate that 
the linear fitting function result in most precise modelling of the proton data.  
• The outcome form fitting on a balanced database with respect to 𝐿𝐸𝑇∗ show 
only small deviations from the fits to the corresponding imbalanced database, 
and a slightly better performance was implied for non-linear fitting compared to 
the linear fits. Consequently, only minor differences are observed in the 
calculated RMSE values as well. However, an exception was observed for fit to 
balanced SOBP data obtained with 𝑓𝐿𝑄𝐶𝑞, which has an increased RMSE.  
4.3.4 Comparison with the Rørvik weighted model 
The five fitting functions with 𝑓𝐿𝑄, 𝑓𝐿𝑄𝐶 , 𝑓𝐿𝑄𝐶𝑞 , 𝑓𝐿𝐸 and 𝑓𝐿𝑄𝐸 were indicated to yield 
best performance in the non-linear fitting both on the unrestricted database in section 
4.3.1 and on the restricted database containing data points with (𝛼 𝛽⁄ )𝑥 < 25 𝐺𝑦 and 
𝐿𝐸𝑇∗ < 20 𝑘𝑒𝑉/𝜇𝑚 in section 4.3.2. These functions were used to obtain fits to proton 
data with (𝛼 𝛽⁄ )𝑥 < 25 𝐺𝑦, including all values of 𝐿𝐸𝑇




with the 𝑅𝐵𝐸𝑚𝑎𝑥 function of the Rørvik model obtained with a weighted dataset 
(RORW), which is derived using a 4th degree polynomial fitting function. In Figure 50, 
the 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationships of the fits are plotted for different (𝛼 𝛽⁄ )𝑥 values 
together with the 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationship according to the RORW model plotted 
for the same values of (𝛼 𝛽⁄ )𝑥.  
It is clear from the figure that the RORW model applies the same assumption for the 
𝑅𝐵𝐸𝑚𝑎𝑥-(𝛼 𝛽⁄ )𝑥 relationship as the fitted curves. While the RORW curves starts to 
decrease with increasing 𝐿𝐸𝑇∗ values at ~30 𝑘𝑒𝑉/𝜇𝑚, this feature is not observed for 
any of the fitted curves. As seen in Figure 50, the 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationships of the 
fits obtained with 𝑓𝐿𝑄, 𝑓𝐿𝑄𝐶 , 𝑓𝐿𝐸 and 𝑓𝐿𝑄𝐸 have very similar characteristics, showing 
that the 𝑅𝐵𝐸𝑚𝑎𝑥 increases with increasing 𝐿𝐸𝑇
∗ with a gradually steeper slope for 
higher 𝐿𝐸𝑇∗ values. The curve from the fit obtained with 𝑓𝐿𝑄𝐶𝑞 has a slightly different 
shape with more distinct fluctuations in the slope. Although the RORW curve also 
show this characteristic, the fluctuations do not coincide for these two curves. From 
Figure 50(c), it is observed that in the ranges of let where the RORW curve is steepest, 
the slope of the 𝑓𝐿𝑄𝐶𝑞 curve is at its lowest. The deviation in the shapes of these curves 
might stem from differences in the applied fitting procedure, as the RORW model is 
derived from a weighted regression, taking the experimental uncertainties of the data 





Figure 50: 𝑅𝐵𝐸𝑚𝑎𝑥 plotted as a function of 𝐿𝐸𝑇
∗ for six different (𝛼 𝛽⁄ )𝑥 values. 
The results from fitting on proton data with (𝛼 𝛽⁄ )𝑥 < 20 𝐺𝑦, using the fitting 
functions from insertion of 𝑓𝐿𝑄, 𝑓𝐿𝑄𝐶, 𝑓𝐿𝑄𝐶𝑞, 𝑓𝐿𝐸 and 𝑓𝐿𝑄𝐸 into Equation (3.3) are 
used to plot the curves in (a), (b), (c), (d) and (e), respectively. In each plot, 
Equations (2.16) and (2.17) are used to plot the 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of let 




4.4 Application of different models 
RBE as a function of LET, dose and (𝛼 𝛽⁄ )𝑥 is shown for a selection of models in 
Figure 51, Figure 52 and Figure 53, respectively. In each figure, the RBE estimates of 
the linear models are shown in (a) and (b), while the estimates of  non-linear models 
are given in (c) and (d). The selection of linear models aimed at showing the effect of 
𝐿𝐸𝑇∗ restrictions and showing the effect of fitting on a balanced database in terms of 
(𝛼 𝛽⁄ )𝑥. The selected non-linear models are the ones that showed best performance on 
the unrestricted database and on the restricted database containing data points that were 
considered most clinically relevant, based on the RMSE values of the fits. In (c) and 
(d) in Figure 51, Figure 52 and Figure 53, the estimated RBE from two of the linear 
models and two of the non-linear models are compared to  RBE estimates obtained 
with coinciding dose, 𝐿𝐸𝑇∗ and (𝛼 𝛽⁄ )𝑥 values using the RORU model, the RORW 
model and the MCN model. 
From Figure 51 it is clear that all the models contradict a constant RBE of 1.1. 
Compared to a constant RBE of 1.1, the models show relatively large agreement, as the 
RBE increases with LET similarly for all models, although panels (e) and (f) reveals 
differences which could have a clinical impact, in particular in the region around 5 
𝑘𝑒𝑉/𝜇𝑚 where the RORW model deviates from the other. The two non-linear models 
from the present work show similarities with the RORW model in this region, as the 
RBE estimates of these models show a slower increase with LET compared to the linear 
models. All models from the present work are more or less in between the RORW and 
RORU models. In panels (a) and (b), the model obtained with a balanced database with 
respect to (𝛼 𝛽⁄ )𝑥 stand out from the other linear models with a steeper increase in 
RBE with LET. The reason for this is not fully understood, and a more detailed analysis 
of the data is required. A possible reason could be that the data points with higher 
(𝛼 𝛽⁄ )𝑥 values, which are given higher weights in the fitting procedure, deviates a lot 
from the low (𝛼 𝛽⁄ )𝑥 data. However, this can not be verified at this point and requires 




As seen in Figure 52, the dose dependency is similar for all the models, both at high 
and low (𝛼 𝛽⁄ )𝑥 values. In panels (e) and (f), wee see that the RBE estimates from 
different models deviate most from each other at doses below 3 Gy. As radiation 
treatment normally is delivered with a fraction doses of 2 Gy, organs at risk normally 
receives doses below 2 Gy and consequently potentially a high RBE. The differences 
are smaller for higher (𝛼 𝛽⁄ )𝑥 values, as seen from comparison of the left and right 
panels in the figure. The dependency of RBE on dose deviates more between the linear 
models in panels (a) and (b) compared to the non-linear models in (c) and (d) which 
have almost identical dose dependencies. 
Both the models from the present work and the three established RORU, RORW and 
MCN models are derived with the same assumption for the dependency of RBE on 
(𝛼 𝛽⁄ )𝑥. This is reflected in Figure 53, as the decrease in RBE with increasing (𝛼 𝛽⁄ )𝑥 
is similar for all the considered models, and the curves mainly differ by their placement 
in the vertical direction. The RBE estimates deviate most between different models for 
low (𝛼 𝛽⁄ )𝑥, where the RORW model also deviates to some degree from the other 
models, as seen clearly in panel (f). From the same panel, it is clear that all models 
from the present work are between the RORU and the MCN models. The approach 
used in section 4.2.2 could in principle be used to find a new (𝛼 𝛽⁄ )𝑥 dependency. As 
a somewhat weaker (𝛼 𝛽⁄ )𝑥 dependency was indicated by the analysis, it is likely that 
this would produce a model which estimates the RBE to decreases slower with 





Figure 51: The RBE for different 𝐿𝐸𝑇∗ values for a monoenergetic beam with 





Figure 52: The RBE for different doses for a monoenergetic beam with a 𝐿𝐸𝑇∗ 






Figure 53: The RBE for different (𝛼 𝛽⁄ )𝑥 values for a monoenergetic beam 




Figure 54 shows the biological (RBE-weighted) dose for a simulated SOBP scenario, 
calculated from three of the linear and two of the non-linear RBE models from the 
present work. Biological doses obtained with a constant RBE of 1.1 and from the 
RORU, RORW and MCN models are given for comparison. It is clear form the figure 
that all the considered variable RBE models largely disagrees with the constant RBE 
(1.1) model, especially at the distal half of the SOBP. Compared to a constant RBE of 
1.1, all variable models, except from the RORU model show an overall agreement. For 
the entrance region between 0 and 2.5 cm, the estimated biological dose from all 
models were below or approximately at the same level as the constant RBE (1.1) model. 
At the proximal part of the SOBP, the RBE estimates deviate more between the models, 
and the RORU model estimates a relatively large biological dose. All the considered 
models estimated an increased RBE towards the distal end of the SOBP, with a steady 
increase in RBE across the SOBP for all models except RORW, which estimated a 
smaller increase in RBE towards the distal end of the SOBP. The LET in this region is 
between 5 and 10 𝑘𝑒𝑉/𝜇𝑚, which is the range of LET values where the RORW model 
RBE estimates deviated most from the other models in Figure 51(f).  
The linear model obtained with all LET values estimates higher RBE than both the 
non-linear models across the SOBP. These three models are derived from relatively 
similar data, as the database contains few data points with LET above 20 𝑘𝑒𝑉/𝜇𝑚 and 
the highest LET value in the database is around 34 𝑘𝑒𝑉/𝜇𝑚. The quartic model is 
similar to the linear model at the proximal part of the SOBP, but the difference between 
these models increase across the SOBP, resulting in a much larger difference in RBE 
estimates at distal end of the SOBP. The opposite trend is seen for the cubic model, 
which is below the linear and quartic models at the proximal part of the SOBP, and 
with a larger increase in RBE with depth ends up giving a similar estimate as the linear 
model at the distal end of the SOBP. The linear models given by the green and purple 
curves are derived from databases with lower restrictions on the upper limit of  LET 
and (𝛼 𝛽⁄ )𝑥. Both these models give lower RBE estimates than the linear model 




scenario are below 10 𝑘𝑒𝑉/𝜇𝑚, and an (𝛼 𝛽⁄ )𝑥 value of 3 Gy was applied in the 
calculations, and the linear models given by green and purple lines are derived from 
restricted databases containing LET and (𝛼 𝛽⁄ )𝑥 values similar to these, it is likely that 
these models provide good RBE estimates for this scenario. The RBE estimates given 
by the models from this work is generally higher than the estimated RBE from the 
MCN model. Compared to the RORW model, the models from this work generally 
gives similar or lower RBE estimates at the proximal part of the SOBP, and higher 
estimates at the distal end of the SOBP.  
Considering all models including the constant RBE model, the deviations in biological 
dose estimates at the proximal part of the SOBP is approximately 0.2 Gy(RBE), while 
the deviations at the distal end of the SOBP is around 0.8 Gy(RBE). The large 
variations in model estimates at the distal end are significant in the context of a clinical 
setting. Thus, applying one of the considered RBE models in a treatment planning 
process, the outcome of treatment planning would be considerably affected by the 





Figure 54: Depth dose distribution of an SOBP in water with model estimates 
obtained with linear and non-linear models from the present work and the 
RORW, RORU and MCN models. In the upper panel, the red curve represents 
the 𝐿𝐸𝑇𝑑 given by the right axis. The lower panel focus on the curves 
representing the biological dose given by the left axis in both panels. An 





A large database was collected and analyzed. The monoenergetic data was evenly 
distributed over the range of LET values, while neither monoenergetic nor SOBP data 
points was evenly distributed over the range of (𝛼 𝛽⁄ )𝑥 values. Linear and non-linear 
regression was performed to obtain fits for 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of LET and (𝛼 𝛽⁄ )𝑥. 
Overall, the analysis showed that the RBE increases with increasing LET and 
decreasing (𝛼 𝛽⁄ )𝑥, which is in line with previous findings in published literature [4]. 
The fitting outcome was most clearly affected by restrictions on the upper range of 
included 𝐿𝐸𝑇∗ values and the lower range of included (𝛼 𝛽⁄ )𝑥 values. Fitting on 
balanced databases showed that the distribution of data over the range of (𝛼 𝛽⁄ )𝑥 values 
in the database can play a significant role for the outcome of fitting. Calculated RMSE 
values indicated similar performance for the linear fits and several of the non-linear 
fits.  
Linear fitting of 𝑅𝐵𝐸𝑚𝑎𝑥 as a function of LET and (𝛼 𝛽⁄ )𝑥 without database 
restrictions resulted in similar fit parameters for all data, monoenergetic data and SOBP 
data. Although the fit parameter for the SOBP data is a little higher than the 
monoenergetic one, the difference is too small to be considered a clear indication of a 
dependency on irradiation condition, as it is likely to be due to experimental 
uncertainties and fluctuations in the data. However, a trend of higher 𝑘 values for the 
SOBP data was observed from linear fitting on restricted databases with reduced upper 
limit of included LET and (𝛼 𝛽⁄ )𝑥 values. These results indicate that the 𝑅𝐵𝐸𝑚𝑎𝑥 is 
dependent on the radiation condition, and irradiation with a SOBP yields a steeper 
increase in 𝑅𝐵𝐸𝑚𝑎𝑥 with increasing LET, compared to the 𝑅𝐵𝐸𝑚𝑎𝑥-LET relationship 
when monoenergetic radiation is used.  
From the analysis of the assumption that 𝑅𝐵𝐸𝑚𝑎𝑥 is inversely proportional with 
(𝛼 𝛽⁄ )𝑥 in section 4.2.2 is clear that a larger database is needed to get more reliable 
results with this procedure. Several of the linear fits are based on too few data points 




The results from the analysis indicated an overall trend of increasing 𝑅𝐵𝐸𝑚𝑎𝑥 with 
decreasing (𝛼 𝛽⁄ )𝑥. However, it could not be verified that the 1/(𝛼 𝛽⁄ )𝑥 dependency 
is a valid assumption for the 𝑅𝐵𝐸𝑚𝑎𝑥-(𝛼 𝛽⁄ )𝑥 relationship of the considered proton 
data. 
Comparison between the linear fits to data with (𝛼 𝛽⁄ )𝑥 values in specific intervals and 
the RORU model showed that the fits to all data and monoenergetic data with low 
(𝛼 𝛽⁄ )𝑥 (≲ 6 𝐺𝑦) had smaller slopes than the corresponding Rørvik lines, while the fits 
to higher (𝛼 𝛽⁄ )𝑥 values had steeper slopes. The same was observed from the 
comparison with the obtained 3D fits applying the assumption that 𝑅𝐵𝐸𝑚𝑎𝑥 is inversely 
proportional with (𝛼 𝛽⁄ )𝑥.This indicates that the predicted 𝑅𝐵𝐸𝑚𝑎𝑥 might be 
overestimated at low (𝛼 𝛽⁄ )𝑥 and underestimated at high (𝛼 𝛽⁄ )𝑥 when this assumption 
is applied. The analysis of the current database therefore implies that the inverse 
dependency of 𝑅𝐵𝐸𝑚𝑎𝑥 on (𝛼 𝛽⁄ )𝑥 is of a weaker character than the  1/(𝛼 𝛽⁄ )𝑥 
relation. Appliance of a dependency more in line of 1/√(𝛼 𝛽⁄ )𝑥 might thus be more 
suited for precise modelling of the proton RBE. This is thus considered a good place 
to start in future investigation of the 𝑅𝐵𝐸𝑚𝑎𝑥-(𝛼 𝛽⁄ )𝑥 relationship.  
The results from fitting on balanced databases demonstrated the potential impact of 
using imbalanced data in the analysis. In Rørvik’s exploration of different published 
phenomenological models from 2018 [22], the distributions of LET and (𝛼 𝛽⁄ )𝑥 in the 
model databases were explored through a violin plot. It was shown that several of the 
considered models were based on imbalanced databases, both in terms of LET and 
(𝛼 𝛽⁄ )𝑥. The Rørvik database, used to derive the RORU and RORW models was shown 
to be balanced with respect to LET. The fits obtained to balanced databases in the 
present work are based on repetitive fitting on randomly chosen samples of data points 
with (𝛼 𝛽⁄ )𝑥 and LET values in different parts of the ranges. A weakness in this 
approach is that some data points will be given higher weight in the fitting procedure, 
i.e. data points in intervals with little data available. Uncertainties in the data may 




are more likely to better reflect the dependencies in the considered range of (𝛼 𝛽⁄ )𝑥 
and LET values. A balanced database is generally more essential when a linear fitting 
procedure is applied, given that non-linear fitting functions are better suited to handle 
an imbalanced database. This can help explaining the large deviations in terms of 
RMSE in the outputs from non-linear fitting on balanced databases.  
As seen in the present work, and previously published phenomenological RBE models, 
the data used in the regression fit plays a significant role. The present analysis of linear 
fitting on restricted databases showed that the applied restrictions on LET largely 
affected the fitting outcome. The significance of the applied upper limit of included 
LET values have previously been demonstrated by Rørvik, who refitted the previously 
published WED model with a lower 𝐿𝐸𝑇𝑑 cut-off to the associated database, resulting 
in a 13% lower fit parameter [22]. From linear fitting on restricted databases, 
indications of a non-linear 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationship was observed. Lowering the 
upper limit of included 𝐿𝐸𝑇∗ values generally resulted in lower 𝑘 values, meaning that 
the slope of the linear 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇
∗ relationship is steeper when higher 𝐿𝐸𝑇∗ values 
are included in the fitting. A trend of increased slope was also observed when data 
points with 𝐿𝐸𝑇∗ < 5 𝑘𝑒𝑉/𝜇𝑚 was excluded from the fitting, which strengthens the 
indication that a non-linear relationship involving larger increase in 𝑅𝐵𝐸𝑚𝑎𝑥 per 
increase in 𝐿𝐸𝑇∗ for higher 𝐿𝐸𝑇∗ values is better suited to model the proton data. Some 
of the results from linear fitting on databases with reduced range of included (𝛼 𝛽⁄ )𝑥 
values indicated that the 𝑅𝐵𝐸𝑚𝑎𝑥-(𝛼 𝛽⁄ )𝑥 relationship might be different for high and 
low (𝛼 𝛽⁄ )𝑥. However, this observation was largely seen in the analysis concerning 
data points with (𝛼 𝛽⁄ )𝑥 < 5 𝐺𝑦, and the inclusion or exclusion of these data. The 
observed trends might therefore be connected to the fact that the data points are not 
evenly distributed across the range of (𝛼 𝛽⁄ )𝑥 values. As the database contains a large 
amount of data with (𝛼 𝛽⁄ )𝑥 < 5 𝐺𝑦, the observed deviations from fits obtained with 
restrictions concerning these data points might be a result of the fact that the database 




The results from linear fitting on restricted databases thus implies the need for further 
investigation of a non-linear dependency of 𝑅𝐵𝐸𝑚𝑎𝑥 on 𝐿𝐸𝑇. Although this was done 
by Rørvik et al [10], investigating the RBE-LET relationship by fitting of polynomials 
from 1st to 5th degree to a database of 85 in vitro data points, further exploration using 
different regression techniques and larger databases is needed.  
The RMSE values of the non-linear fits to the unrestricted database indicated that 
several of the non-linear fitting functions yields similar goodness of fit as the linear 
fitting function. However, it should be kept in mind that RMSE is only a measure of 
the mean distance between the predicted values and the actual values, and an overfitted 
model can therefore be falsely indicated to be a good fit by only considering the RMSE. 
The visualization of the 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇 relationships obtained with non-linear fitting 
showed that several of the fits had similar characteristics as the linear fit, as the slopes 
of the curves were similar for lower and higher values of 𝐿𝐸𝑇∗. The present analysis 
of linear and non-linear fitting do not clearly favor one regression technique over the 
other. However, as the results from linear fitting on restricted databases indicated a 
non-linear trend, and a general trend of lower RMSE values for non-linear fits was 
observed, the analysis implies that a non-linear 𝑅𝐵𝐸𝑚𝑎𝑥-𝐿𝐸𝑇 relationship might be 
preferred. A weak indication was observed that the 4th degree polynomial fitting 
function was best suited to model the data, which is in line with previous results from 
Rørviks investigation of a non-linear RBE-LET relationship [10]. From the SOBP 
scenario, it was observed that the RBE estimates from the quartic model is very similar 
to the estimates given by the linear models obtained with the strictest database 
restrictions (given by purple and green curves in Figure 54). It was pointed out that 
these two models are likely to be more applicable in the SOBP scenario, based on the 
(𝛼 𝛽⁄ )𝑥 and LET values used to derive them. The fact that the RBE estimates of the 
quartic model resemble these two models estimates might thus indicate a good 





The appliance of models in an SOBP scenario clearly show the large deviations 
between the different RBE models.   
Finally, it should be noted that as RBE models are based on in vitro data, the translation 
validity of the results to in vivo is debatable, and the uncertainties connected to the 
appliance of the results in a clinical setting is typically not known. It is therefore of 
great importance to compare in vitro based predictions to available in vivo and clinical 
data on RBE. The need for further in vivo studies at lower fractional doses have 
previously been demonstrated [56]. 
Future work 
• The present analysis of a possible RBE dependence on the irradiation condition 
(monoenergetic vs SOBP) showed weak indications that such a dependence 
could be present. However, the results were not conclusive, and further 
investigation is needed to verify whether such a trend is present or not. It was 
seen in the present work that more work is needed to isolate this dependency in 
the analyses, as it could not be determined whether the observed deviations in 
the results from the present analyses was due to a dependency on irradiation 
condition or other effects. A good place to start is thus to collect a balanced 
database containing similar amount of data obtained from irradiation 
experiments using a monoenergetic beam and experiments using an SOBP 
beam. Analyses of such a database could involve fits to only monoenergetic data 
and only SOBP data, and investigate whether the predictions from these fits 
show different trends or not.  
• The present work indicated that the dependency of 𝑅𝐵𝐸𝑚𝑎𝑥 on (𝛼 𝛽⁄ )𝑥 is 
somewhat weaker than 1/(𝛼 𝛽⁄ )𝑥. A 1/√(𝛼 𝛽⁄ )𝑥 was suggested, as it might be 
a good candidate. However, more work is needed to explore this dependency, 
and potentially find a more suitable one than the widely used assumption that 
𝑅𝐵𝐸𝑚𝑎𝑥 is inversely proportional with (𝛼 𝛽⁄ )𝑥. The procedure applied in 




• A non-linear RBE-LET relationship should be further explored. Although 
several results from the present analysis imply a non-linear trend, further 
investigation is needed to determine if a non-linear relationship is preferred over 
a linear relation, or perhaps the other way around.  
• Comparisons of in vitro based predictions to available in vivo data both from 
experimental and clinical settings is much needed to fully understand possible 
uncertainties in the appliance of RBE models derived from in vitro data in a 
clinical setting.  
• Further exploration of the appliance of different regression techniques and 
methods to evaluate and compare regression outputs can contribute to reduced 
uncertainties in the RBE modelling. It was seen in the present work that the 
evaluation and comparison based only on RMSE did not provide conclusive 
results, and might not fully cover all perspectives and deviations in the results.  
As RMSE can only provide an estimate of the goodness of fit and do not detect 
overfitted models, other evaluation methods and statistical tests should be 
considered.  
• Application of machine learning (ML) algorithms in RBE modelling could also 
be looked into. ML algorithms designed for data preprocessing can be a valuable 
tool for outlier detection and data selection, and  regression analysis based on 







In the present study, a database of in vitro proton data was analysed in the framework 
of a phenomenological proton RBE model, with the main goal of exploring how data 
selection, regression methods and model assumptions affect the RBE estimation. 
Investigating the RBE dependence on (𝛼 𝛽⁄ )𝑥, implied a weaker dependency than the 
widely assumed 1/(𝛼 𝛽⁄ )𝑥 relation. Linear fitting on both the unrestricted and 
restricted databases showed a trend of higher 𝑘 values for the SOBP data compared to 
the monoenergetic data, indicating a dependency of RBE on the radiation condition, 
with a steeper increase in RBE with increasing LET when an SOBP beam is used, 
compared to applying a monoenergetic beam. Restrictions on the range of included 
(𝛼 𝛽⁄ )𝑥 values indicated a different RBE-(𝛼 𝛽⁄ )𝑥 relationship for low and high 
(𝛼 𝛽⁄ )𝑥, which is in line with the results from investigation of the 1/(𝛼 𝛽⁄ )𝑥 relation. 
Reducing the upper limit of included LET values, a clear trend of lower 𝑘 values was 
observed, indicating that the slope of the applied linear RBE-LET relationship is 
smaller for lower LET and thus implying that non-linear models might provide a better 
representation of the RBE-LET relationship. Further investigation applying non-linear 
fitting on the proton data implied better performance for several of the non-linear fits 
compared to linear fits to the same data. The quartic fitting function showed overall 
best performance on the current database. The present analyses generally highlighted 
the pronounced effects of data selection on model output and RBE predictions. This 
was also demonstrated by obtaining RBE estimates from different models for a SOBP 
scenario, showing large differences between the models. Published RBE models show 
large variations in RBE estimates, and these variations should be reduced to be able to 
apply a variable RBE in clinical settings. Many different model assumptions are 
applied, and more work is needed to decide which assumptions result in most accurate 
RBE modelling. From the SOBP scenario in the present work, one can deduce that if 
one of the considered variable RBE models were to replace the assumption if a constant 
proton RBE=1.1, the RORW model and the quartic model from the present work could 




RBE=1.1, but not to the same extent as several other models, such as the RORU model. 
Both these models give increasing RBE estimates across the SOBP, which is in line 
with previous observations. As the models vary in RBE estimates at the distal end of 
the SOBP, further investigation of the RBE in this region could be the final step to 






Figure A1: Proton 𝐿𝐸𝑇∗ plotted against (𝛼 𝛽⁄ )𝑥 values, without the restriction 
on included (𝛼 𝛽⁄ )𝑥 values that was applied in Figure 17. In (a), all proton data 
points are shown. Data points obtained using monoenergetic radiation and 





Figure A2: Comparison of the linear fits to the monoenergetic proton data 
(shown in Figure 21) and the RORU model. (a)-(g) shows the regression fits 
(colored lines), the RORU lines obtained by putting the mean of the (𝛼 𝛽⁄ )𝑥 
values for the data points in each interval of (𝛼 𝛽⁄ )𝑥 into Equation (2.15) (black 
lines) and the area spanned by the curves obtained with Equation (2.15) using 
the upper and lower limits for the (𝛼 𝛽⁄ )𝑥 value in each interval (colored area). 
In (a), the area is shown for a lower limit of (𝛼 𝛽⁄ )𝑥 = 1 𝐺𝑦, assuming that 
clinical use will not involve (𝛼 𝛽⁄ )𝑥 values below this. The slope of the RORU 
lines are also given in (a)-(g). The RORU lines and limit areas for each (𝛼 𝛽⁄ )𝑥 





Figure A3: Comparison of the linear fits to the SOBP proton data (shown in 
Figure 22) and the RORU model. (a)-(g) shows the regression fits (colored 
lines), the RORU lines obtained by putting the mean of the (𝛼 𝛽⁄ )𝑥 values for 
the data points in each interval of (𝛼 𝛽⁄ )𝑥 into Equation (2.15) (black lines) and 
the area spanned by the curves obtained with Equation (2.15) using the upper 
and lower limits for the (𝛼 𝛽⁄ )𝑥 value in each interval (colored area). In (a), the 
area is shown for a lower limit of (𝛼 𝛽⁄ )𝑥 = 1 𝐺𝑦, assuming that clinical use will 
not involve (𝛼 𝛽⁄ )𝑥 values below this. The slope of the RORU lines are also 
given in (a)-(g). The RORU lines and limit areas for each (𝛼 𝛽⁄ )𝑥 interval are 





Figure A4: (a)-(g): The linear fits in Figure 21 for monoenergetic proton data 
divided into seven subsets are shown (colored lines) together with the MCN 
lines obtained by using the mean (𝛼 𝛽⁄ )𝑥 value for the data points in each 
subset as an input in Equation (2.11) (black lines), The slope of the MCN lines 
are given in each plot. The area between the MCN lines obtained by using the 
upper and lower limits of each (𝛼 𝛽⁄ )𝑥 interval as an input in Equation (2.11) 
are also shown (colored areas). A lower limit of (𝛼 𝛽⁄ )𝑥 = 1 𝐺𝑦 is used in (a), 
assuming that clinical use will not involve (𝛼 𝛽⁄ )𝑥 values below this. The MCN 





Figure A5: (a)-(g): The linear fits in Figure 22 for SOBP proton data divided 
into seven subsets are shown (colored lines) together with the MCN lines 
obtained by using the mean (𝛼 𝛽⁄ )𝑥 value for the data points in each subset 
as an input in Equation (2.11) (black lines), The slope of the MCN lines are 
given in each plot. The area between the MCN lines obtained by using the 
upper and lower limits of each (𝛼 𝛽⁄ )𝑥 interval as an input in Equation (2.11) 
are also shown (colored areas). A lower limit of (𝛼 𝛽⁄ )𝑥 = 1 𝐺𝑦 is used in (a), 
assuming that clinical use will not involve (𝛼 𝛽⁄ )𝑥 values below this. The MCN 





Figure A6: The linear regression fits to monoenergetic proton data points from 
Figure 21 are shown in (a-g) together with lines obtained from the fitted plane 
to monoenergetic data from Figure 18(b). These lines are plotted by inserting 
the obtained fit parameter 𝑘 = 0.45 into Equation (3.2) and using the mean 
(𝛼 𝛽⁄ )𝑥 value of the data points in each of the subsets as an input for (𝛼 𝛽⁄ )𝑥 
in the equation. The slopes of the lines from the 3D fit are given in each plot. 
The colored area in each plot is obtained by using the same equation, and the 
upper and lower boundaries in each interval of (𝛼 𝛽⁄ )𝑥 values. In (h), the lines 





Figure A7: The linear regression fits to SOBP proton data points from Figure 
22 are shown in (a-g) together with lines obtained from the fitted plane to 
SOBP data from Figure 18(c). These lines are plotted by inserting the obtained 
fit parameter 𝑘 = 0.48 into Equation (3.2) and using the mean (𝛼 𝛽⁄ )𝑥 value of 
the data points in each of the subsets as an input for (𝛼 𝛽⁄ )𝑥 in the equation. 
The slopes of the lines from the 3D fit are given in each plot. The colored area 
in each plot is obtained by using the same equation, and the upper and lower 
boundaries in each interval of (𝛼 𝛽⁄ )𝑥 values. In (h), the lines from the 3D fit 
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